polymyalgia rheumatica: Polymyalgia rheumatica is a common inflammatory condition that often affects people over the age of 50 years. Characteristic symptoms are shoulder and hip girdle pain and prolonged morning stiffness. Markers of inflammation are often elevated.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5149 |
4. Check minimum number of eventsNone |
5149 |
5. Include endpointsNone |
5149 |
6. Filter based on genotype QC (FinnGen only) |
5149 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M35
- Name in latin
- Polymyalgia rheumatica
Similar endpoints
↥List of similar endpoints to
Polymyalgia rheumatica
based on the number of shared cases.
Similar with more cases:
- Other systemic involvement of connective tissue (FG)
- Other systemic involvement of connective tissue
- Systemic connective tissue disorders
- Finngen Rheumatological endpoints
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 42642 | 28465 | 13837 |
| Only index persons | 34295 | 22973 | 11322 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.67 | 0.82 | 0.39 |
| Only index persons | 0.71 | 0.84 | 0.43 |
| Median age at first event (years) | |||
| Whole population | 74.56 | 75.24 | 73.15 |
| Only index persons | 73.96 | 74.64 | 72.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5149 | 2985 | 2164 |
| Unadjusted period prevalence (%) | 0.99 | 1.02 | 0.95 |
| Median age at first event (years) | 71.12 | 70.64 | 71.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4558
- Matched controls
- 45577
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.0
323.0
769
1007
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.3
323.0
1207
2454
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.1
323.0
3032
12710
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
7.9
323.0
1106
1782
M35.3
ICD-10 Finland
Polymyalgia rheumatica
5150.9
323.0
4449
389
H02AB06
ATC
prednisolone; systemic
17.5
323.0
4113
15732
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
250.6
323.0
390
17
PAW37
NOMESCO Finland
Biopsy of temporal artery
108.0
312.1
340
34
H02AB07
ATC
prednisone; oral
3.7
225.6
1205
4081
M05BA04
ATC
alendronic acid; oral
4.0
217.6
1016
3056
A02BC02
ATC
pantoprazole; systemic
2.8
206.5
3466
24137
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
10.1
189.4
394
422
M13.9
ICD-10 Finland
Arthritis, unspecified
4.8
177.4
648
1512
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.0
174.7
616
1383
P01BA02
ATC
hydroxychloroquine; oral
4.5
166.7
659
1661
L88
ICPC
Rheumatoid/seropositive arthritis
7.1
164.4
426
649
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
1512.6
148.7
144
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
85.1
146.3
164
20
M25.5
ICD-10 Finland
Pain in joint
2.4
134.4
1457
7390
M79.1
ICD-10 Finland
Myalgia
3.1
126.4
783
2822
M35.5
ICD-10 Finland
Multifocal fibrosclerosis
1230.8
123.5
120
*
7250A
ICD-9 Finland
Polymyalgia rheumatica[POLYMYALGIA RHEUMATICA]
+∞
110.9
106
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
102.8
490
1431
N02BE01
ATC
paracetamol; systemic, rectal
2.5
97.6
4029
34394
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
94.5
2340
16194
M79.6
ICD-10 Finland
Pain in limb
2.0
94.3
1785
11174
R50.9
ICD-10 Finland
Fever, unspecified
2.6
94.2
805
3494
L18
ICPC
Muscle pain
4.9
91.2
315
675
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
5.2
83.9
277
564
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
83.8
764
3415
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
83.5
961
4824
N02AX02
ATC
tramadol; systemic, rectal
1.8
81.1
2110
14554
M01AH05
ATC
etoricoxib; oral
1.8
80.9
2442
17700
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.0
80.4
274
578
M35.1
ICD-10 Finland
Other overlap syndromes
791.8
79.6
78
*
M79.7
ICD-10 Finland
Fibromyalgia
6.0
78.3
225
388
A07EC01
ATC
sulfasalazine; oral, rectal
3.0
77.2
485
1726
N03AX16
ATC
pregabalin; oral
2.0
75.0
1234
7171
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
70.4
469
1731
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
4.4
68.1
262
625
N03AX12
ATC
gabapentin; oral
2.1
63.2
812
4221
M54.5
ICD-10 Finland
Low back pain
1.8
62.4
1422
9156
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
61.1
1559
10387
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
5.4
60.6
189
360
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.2
60.5
197
394
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.9
60.4
175
305
L04AX01
ATC
azathioprine; systemic
4.2
59.2
236
582
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.9
57.2
1124
6847
J01DB01
ATC
cefalexin; oral
1.7
55.1
3492
29786
M05BA07
ATC
risedronic acid; oral
3.1
54.6
317
1061
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
54.3
1975
14444
A01
ICPC
Pain general/multiple sites
2.5
53.9
470
2020
C03CA01
ATC
furosemide; systemic
1.6
50.8
1858
13527
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
50.6
1349
8986
A02BC05
ATC
esomeprazole; systemic
1.6
50.4
1846
13435
A02BC03
ATC
lansoprazole; oral
1.7
50.3
1473
10080
I77.6
ICD-10 Finland
Arteritis, unspecified
37.6
49.4
63
17
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.7
49.1
354
1362
M31.6
ICD-10 Finland
Other giant cell arteritis
171.8
48.9
51
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
48.5
416
1768
M03BX02
ATC
tizanidine; oral
1.6
48.0
2344
18280
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
47.3
1608
11417
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.4
46.9
244
754
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
46.1
995
6185
L20
ICPC
Joint symptom/complaint NOS
3.6
46.0
220
636
R06.0
ICD-10 Finland
Dyspnoea
1.7
45.7
1276
8563
S18
ICPC
Laceration/cut
1.6
45.4
1949
14644
R52.9
ICD-10 Finland
Pain, unspecified
2.3
44.9
434
1960
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
44.8
699
3877
M48.0
ICD-10 Finland
Spinal stenosis
1.9
44.5
745
4242
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
44.3
2050
15651
M01AC06
ATC
meloxicam; systemic, rectal
1.6
43.6
1630
11794
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
43.2
1411
9856
N06AX21
ATC
duloxetine; oral
2.2
43.0
468
2233
UJF32
NOMESCO Finland
Coloscopy
1.6
42.4
1284
8779
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
42.4
634
3456
J01CA04
ATC
amoxicillin; systemic
1.6
42.2
3249
27839
L08
ICPC
Shoulder symptom/complaint
1.8
41.6
903
5595
SPAT1263
SPAT
Sampling
1.5
41.4
1892
14325
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
41.2
517
2623
L04AA13
ATC
leflunomide; oral
3.9
40.7
172
448
L28
ICPC
Limited function/disability (L)
1.7
40.4
935
5904
L03
ICPC
Low back symptom/complaint
1.7
40.2
1037
6762
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
400.9
40.1
40
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
39.9
986
6345
M05BX04
ATC
denosumab; parenteral
2.4
39.8
352
1514
M01AB05
ATC
diclofenac; systemic, rectal
1.5
39.6
2689
22187
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
39.4
1402
9955
M01AH01
ATC
celecoxib; oral (coxibs)
1.7
38.2
904
5737
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
37.5
36
*
A02BC01
ATC
omeprazole; systemic
1.6
37.1
1343
9543
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.9
36.7
590
3289
R53
ICD-10 Finland
Malaise and fatigue
1.7
36.7
1005
6639
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
36.5
594
3330
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
36.3
1116
7599
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
36.2
1058
7110
L99
ICPC
Musculoskeletal disease other
4.0
35.8
147
373
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
35.5
598
3388
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.3
35.1
349
1592
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
35.0
1306
9325
J01MA02
ATC
ciprofloxacin; systemic
1.5
34.5
1798
13835
M70.6
ICD-10 Finland
Trochanteric bursitis
1.8
34.4
622
3610
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
34.3
1408
10268
M13.0
ICD-10 Finland
Polyarthritis, unspecified
5.8
33.7
97
169
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
33.7
616
3586
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
33.3
717
4398
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
32.7
1901
14909
H02AB04
ATC
methylprednisolone; systemic
1.8
32.7
673
4067
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.5
32.6
120
275
M01AE02
ATC
naproxen; oral, rectal
1.5
32.1
2168
17504
L01
ICPC
Neck symptom/complaint
1.8
31.9
572
3305
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
31.8
1401
10342
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.2
31.6
124
303
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
31.3
354
1712
L13
ICPC
Hip symptom/complaint
1.7
31.2
808
5222
M35.7
ICD-10 Finland
Hypermobility syndrome
60.4
31.1
36
6
Z71.8
ICD-10 Finland
Other specified counselling
1.6
30.9
900
6004
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
30.7
753
4793
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
29.8
883
5910
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.5
29.6
238
973
R51.80
ICD-10 Finland
Headache
1.8
29.5
531
3067
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.9
29.2
182
640
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
29.1
1850
14661
L19
ICPC
Muscle symptom/complaint NOS
3.4
29.0
146
441
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
28.9
494
2805
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
28.9
724
4628
N06AA09
ATC
amitriptyline; systemic
1.8
28.8
509
2923
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
28.6
788
5167
L17
ICPC
Foot/toe symptom/complaint
1.5
28.4
1093
7786
SPAT1153
SPAT
Removal of sutures
1.5
28.2
1465
11133
R03AC02
ATC
salbutamol; inhalant
1.4
27.9
2044
16594
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
27.9
418
2262
J01AA02
ATC
doxycycline; systemic
1.5
27.8
3321
29538
ACC51
NOMESCO Finland
Release of median nerve
2.1
27.5
325
1599
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
27.4
742
4840
WX110
NOMESCO Finland
Local anesthesy
1.4
27.0
2535
21477
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
26.5
1638
12839
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
26.3
3511
31683
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
26.3
528
3153
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.9
26.3
110
286
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
10.1
26.1
52
52
J02AC01
ATC
fluconazole; systemic
1.5
26.1
1395
10623
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
26.1
873
6001
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
26.0
772
5148
C07AB07
ATC
bisoprolol; oral
1.4
26.0
2376
19968
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
25.9
451
2573
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
25.8
1765
14077
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.6
25.6
718
4719
L15
ICPC
Knee symptom/complaint
1.5
25.5
912
6363
J01FA06
ATC
roxithromycin; oral
1.4
25.1
1659
13129
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
6.3
25.1
67
107
TPX00
NOMESCO Finland
Biopsy of artery or vein
58.3
25.0
29
5
ZX120
NOMESCO Finland
Intravenous
1.9
24.8
419
2363
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
24.7
1649
13063
M31.3
ICD-10 Finland
Wegener granulomatosis
251.5
24.7
25
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
24.6
704
4646
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
24.5
1915
15596
B01AB05
ATC
enoxaparin; parenteral
1.4
24.5
1409
10850
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
24.4
2937
25758
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
6.9
24.4
61
89
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
24.3
2428
20615
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.7
24.3
581
3654
SPAT1301
SPAT
No procedures
1.4
24.1
1441
11173
S97
ICPC
Chronic ulcer skin
2.1
24.0
301
1516
A03
ICPC
Fever
1.8
23.9
468
2771
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.8
23.9
435
2515
J01MA12
ATC
levofloxacin; systemic
1.5
23.8
845
5875
M05BA06
ATC
ibandronic acid; systemic
2.9
23.8
145
503
SPAT1310
SPAT
Counselling related to known health issue
1.4
23.8
1330
10176
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.9
23.8
99
257
N02AA05
ATC
oxycodone; systemic
1.6
23.5
758
5147
R60.0
ICD-10 Finland
Localized oedema
1.7
23.4
563
3540
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
23.3
501
3049
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
23.3
1226
9266
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
23.2
779
5343
G47.3
ICD-10 Finland
Sleep apnoea
1.6
23.1
754
5133
L95
ICPC
Osteoporosis
2.4
22.8
197
837
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
22.7
993
7221
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
22.7
648
4267
R06AE07
ATC
cetirizine; oral
1.4
22.7
1563
12403
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
5.6
22.4
66
120
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
22.2
401
2312
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
22.0
598
3883
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
4.5
22.0
78
174
R42
ICD-10 Finland
Dizziness and giddiness
1.5
21.9
1078
8016
E0000UV
ATC
NA
1.4
21.9
1540
12239
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
21.8
2127
17852
A98
ICPC
Health maint/preventive medicine
1.5
21.8
3918
36526
SPAT1254
SPAT
Administration of medicine
1.5
21.8
729
4988
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
21.8
1137
8557
G44.2
ICD-10 Finland
Tension-type headache
1.7
21.7
466
2833
Z00.0
ICD-10 Finland
General medical examination
1.5
21.7
771
5348
A02BA02
ATC
ranitidine; systemic
1.5
21.5
955
6955
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
21.4
680
4593
SPAT1255
SPAT
Intravenous administration of medicine
1.9
21.4
315
1691
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.6
21.4
547
3496
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
21.2
151
578
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
21.1
733
5055
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.6
20.9
156
612
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.3
20.9
191
838
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.0
20.5
254
1275
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
20.5
361
2061
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
20.4
1404
11088
TNG10
NOMESCO Finland
Puncture of knee
4.2
20.3
77
184
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.4
20.3
180
775
L86
ICPC
Back syndrome with radiating pain
2.0
20.1
253
1277
R52.2
ICD-10 Finland
Other chronic pain
2.6
20.1
148
579
J01FA10
ATC
azithromycin; systemic
1.3
20.0
1939
16176
M01AX17
ATC
nimesulide; oral
1.4
19.8
1116
8492
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
19.8
545
3547
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.4
19.8
175
755
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
19.7
365
2121
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.8
19.7
83
219
L12
ICPC
Hand/finger symptom/complaint
1.6
19.6
537
3489
J01DA01
ATC
[U] cefalexin; systemic
1.3
19.6
2532
22038
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
200.8
19.6
20
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
19.3
1064
8061
H03AA01
ATC
levothyroxine sodium; systemic
1.4
19.2
1001
7500
J01MA14
ATC
moxifloxacin; systemic
1.8
19.2
376
2220
-1
NOMESCO Finland
NA
1.4
19.2
1048
7923
SPAT1262
SPAT
Handing over of treatment supplies
1.5
19.1
815
5868
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
6.2
19.0
51
83
M04AA01
ATC
allopurinol; systemic
1.5
19.0
658
4525
Z01.2
ICD-10 Finland
Dental examination
1.4
18.9
1328
10489
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
18.8
684
4756
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.4
18.8
159
669
44638
ICD-8 Finland
Polyarteritis nodosa and allied conditions, Polymyalgia arteritica (rheumatica)
+∞
18.8
18
*
SPAT1229
SPAT
Assessment of need for aid
1.7
18.7
431
2673
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.7
18.6
131
498
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.9
18.6
291
1595
SPAT1252
SPAT
Overall medication plan or its review
1.7
18.5
370
2198
C10AA07
ATC
rosuvastatin; oral
1.4
18.5
1048
7966
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
18.5
655
4529
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
18.5
911
6749
J01FF01
ATC
clindamycin; systemic
1.4
18.5
1038
7882
D07AC01
ATC
betamethasone; topical
1.4
18.4
1346
10691
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
18.4
835
6081
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
18.4
244
1258
SPAT1211
SPAT
Application of soft bandage
1.7
18.4
407
2494
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
18.4
1322
10475
A29
ICPC
General symptom/complaint other
1.6
18.3
499
3240
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
18.2
377
2269
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
18.1
804
5829
A46
ICD-10 Finland
Erysipelas
1.5
18.1
649
4496
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
18.0
1130
8745
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
17.9
1248
9824
R07.3
ICD-10 Finland
Other chest pain
1.7
17.8
411
2551
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.1
17.7
97
315
A04
ICPC
Weakness/tiredness general
1.5
17.7
570
3852
R01AD09
ATC
mometasone; nasal
1.3
17.7
1485
12042
M35.2
ICD-10 Finland
Behçet disease
+∞
17.7
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
17.5
865
6397
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
17.4
490
3204
R03DC03
ATC
montelukast; oral
1.6
17.4
538
3602
M01AX05
ATC
glucosamine; oral
1.4
17.3
1064
8188
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.2
17.3
187
887
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.1
17.3
191
913
SPAT1216
SPAT
Assessment of functional ability
1.4
17.2
796
5813
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
17.0
913
6855
M01AH02
ATC
rofecoxib; oral
1.5
17.0
632
4407
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.6
17.0
125
489
NF1DA
NOMESCO Finland
X-ray of hips
2.5
16.9
133
541
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
3.6
16.9
75
208
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.8
16.9
72
193
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
16.8
320
1872
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
16.8
188
906
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
16.7
522
3498
C10AA05
ATC
atorvastatin; oral
1.3
16.7
1770
14830
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.2
16.7
167
764
B01AF01
ATC
rivaroxaban; oral
1.5
16.5
581
4007
M54.2
ICD-10 Finland
Cervicalgia
1.9
16.4
246
1328
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
16.3
1506
12358
K02.1
ICD-10 Finland
Caries of dentine
1.3
16.2
1782
14987
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
4.4
16.2
58
133
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
16.1
1747
14664
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
16.1
322
1914
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
16.1
1774
14919
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
16.1
310
1822
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.9
16.1
226
1195
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
16.0
908
6876
M02AA07
ATC
piroxicam; topical
1.3
16.0
1649
13731
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
15.9
785
5797
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.8
15.9
256
1421
KMAK
NOMESCO Finland
NA
1.3
15.9
1675
13995
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
15.8
695
5015
RD211
NOMESCO Finland
NA
2.1
15.8
181
883
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
15.8
666
4767
SPAT1097
SPAT
Recording of ECG
1.5
15.6
687
4960
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.2
15.5
152
692
EBA00
NOMESCO Finland
Extraction of tooth
1.4
15.5
1118
8819
WZA90
NOMESCO Finland
Other doctors statement
1.4
15.4
764
5643
N06AX11
ATC
mirtazapine; oral
1.3
15.3
1223
9796
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
15.3
1146
9090
ZXA10
NOMESCO Finland
Bilateral
1.4
15.3
834
6273
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
15.2
1191
9505
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
15.1
1267
10217
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.4
15.1
132
565
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
15.1
466
3110
H02AB09
ATC
hydrocortisone; systemic
2.8
15.1
94
335
A28
ICPC
Limited function/disability NOS
1.4
15.1
812
6090
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.8
14.9
37
55
R02
ICPC
Shortness of breath/dyspnoea
1.5
14.9
516
3537
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
14.8
228
1246
XG410
NOMESCO Finland
Flow-volume spirometry
2.0
14.8
178
886
M33.2
ICD-10 Finland
Polymyositis
56.8
14.8
17
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.9
14.8
87
299
AA1AD
NOMESCO Finland
CT of head and brain
1.3
14.7
1103
8742
L04AC07
ATC
tocilizumab; parenteral
13.2
14.7
25
19
I50.0
ICD-10 Finland
Congestive heart failure
1.6
14.6
428
2820
C08CA01
ATC
amlodipine; oral
1.3
14.6
1718
14520
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
14.6
14
*
SPAT1325
SPAT
Vaccination
1.3
14.6
1584
13247
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
2.1
14.6
169
827
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.3
14.5
134
591
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.7
14.5
327
2011
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.2
14.4
154
728
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
14.4
1789
15222
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
14.4
345
2162
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.8
14.3
242
1368
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
14.1
162
792
L11
ICPC
Wrist symptom/complaint
1.7
14.0
274
1618
207
Kela drug reimbursment
Chronic arrhythmias
1.4
14.0
788
5946
SPAT1260
SPAT
Consultation of another employee
1.4
14.0
734
5471
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.4
14.0
119
506
P01AB01
ATC
metronidazole; oral, rectal
1.3
13.8
1418
11738
G04BD12
ATC
mirabegron; oral
1.5
13.8
479
3287
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.6
13.8
346
2195
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
13.8
431
2887
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
2.2
13.8
143
670
T90
ICPC
Diabetes non-insulin dependent
1.3
13.8
987
7754
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
13.8
1456
12106
ZX140
NOMESCO Finland
Intra articular
4.8
13.7
45
95
M60.9
ICD-10 Finland
Myositis, unspecified
6.4
13.6
35
55
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
13.6
614
4449
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.9
13.6
194
1034
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
13.6
745
5598
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.6
13.5
96
368
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
13.5
13
*
4AC0L
NOMESCO Finland
NA
+∞
13.5
13
*
4AC0X
NOMESCO Finland
NA
+∞
13.5
13
*
J05AB01
ATC
aciclovir; systemic
1.4
13.5
775
5862
A01AB09
ATC
miconazole; local oral
1.6
13.5
401
2651
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
13.5
1560
13115
H53.1
ICD-10 Finland
Subjective visual disturbances
1.8
13.4
229
1294
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.5
13.4
62
180
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
13.3
391
2582
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
13.2
436
2956
N05CF01
ATC
zopiclone; oral
1.3
13.2
1452
12116
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
13.2
457
3131
WX320
NOMESCO Finland
Spinalanesthesy
1.3
13.2
934
7316
318
Kela drug reimbursment
Teriparatide
5.0
13.2
41
82
N30.0
ICD-10 Finland
Acute cystitis
1.4
13.1
613
4466
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
13.1
393
2606
XX9XE
NOMESCO Finland
Other ultrasound examination
4.7
13.0
43
92
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
13.0
380
2508
M02AA10
ATC
ketoprofen; topical
1.4
12.9
668
4962
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
12.9
290
1784
R01AD08
ATC
fluticasone; nasal
1.3
12.8
921
7229
WX290
NOMESCO Finland
Other blockade of nerve
1.3
12.8
1141
9246
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.1
12.7
137
651
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
12.7
217
1231
WX002
NOMESCO Finland
Sedation and analgesia
1.4
12.6
820
6329
NG1DA
NOMESCO Finland
X-ray of knees
2.7
12.6
85
320
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.4
12.6
559
4030
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.8
12.5
201
1116
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
12.5
564
4085
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
12.4
1304
10797
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
4.6
12.4
42
92
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
2.4
12.4
106
452
M10.9
ICD-10 Finland
Gout, unspecified
1.6
12.4
295
1844
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.7
12.4
255
1528
M01AB55
ATC
diclofenac, combinations; oral
1.6
12.4
339
2198
B01AA03
ATC
warfarin; systemic
1.3
12.4
1089
8797
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
12.4
331
2136
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.5
12.4
447
3091
R03BB04
ATC
tiotropium bromide; inhalant
1.5
12.3
447
3092
L29
ICPC
Musculoskeletal sympt/complt other
1.6
12.3
302
1903
H02AB02
ATC
dexamethasone; systemic
0.6
12.3
167
2810
R03BA05
ATC
fluticasone; inhalant
1.4
12.2
650
4848
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
1.9
12.2
175
936
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.6
12.2
53
147
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
12.2
174
926
R06AX22
ATC
ebastine; oral
1.4
12.0
510
3645
XA402
NOMESCO Finland
ENMG
2.4
12.0
100
420
C10AX09
ATC
ezetimibe; oral
1.5
12.0
440
3055
HMAK
NOMESCO Finland
NA
1.5
12.0
360
2389
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
4.0
11.9
46
115
H25.8
ICD-10 Finland
Other senile cataract
1.4
11.8
611
4532
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
11.8
239
1426
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
11.8
323
2094
J01FA09
ATC
clarithromycin; systemic
1.3
11.8
1040
8396
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
11.8
420
2897
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
11.8
167
888
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
11.7
336
2202
B01AF02
ATC
apixaban; oral
1.4
11.7
494
3530
ZXA05
NOMESCO Finland
Left side
1.3
11.6
1121
9162
C10AA01
ATC
simvastatin; oral
1.2
11.6
2155
19081
E000001
ATC
NA
1.4
11.6
723
5538
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
22.9
11.6
16
7
X58
ICD-10 Finland
Exposure to other specified factors
1.5
11.5
416
2874
AN1
HP
Coronary angiography
1.4
11.5
588
4353
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.4
11.5
97
412
M54.1
ICD-10 Finland
Radiculopathy
2.0
11.5
140
703
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
11.5
11
*
M45
ICD-10 Finland
Ankylosing spondylitis
2.8
11.4
71
253
4AC07
NOMESCO Finland
NA
120.3
11.4
12
*
H05AA02
ATC
teriparatide; parenteral
4.8
11.4
37
78
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
11.4
255
1570
N01
ICPC
Headache
1.6
11.3
261
1618
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
3.4
11.3
53
157
R05
ICPC
Cough
1.3
11.2
801
6263
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
11.1
256
1586
L14
ICPC
Leg/thigh symptom/complaint
1.6
11.1
308
2002
A07AA02
ATC
nystatin; oral
1.6
11.1
283
1801
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
11.1
239
1456
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
11.1
915
7314
J01CA08
ATC
pivmecillinam; oral
1.3
11.0
1607
13817
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
11.0
825
6500
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
11.0
319
2100
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
11.0
200
1157
R05
ICD-10 Finland
Cough
1.3
10.9
731
5658
A08
ICPC
Swelling
1.8
10.9
194
1114
XW000
NOMESCO Finland
Bone marrow biopsy
1.8
10.9
170
936
WZC30
NOMESCO Finland
Teaching
1.4
10.9
478
3440
C01DA14
ATC
isosorbide mononitrate; oral
1.3
10.8
874
6957
XKD00
NOMESCO Finland
Uroflowmetry
1.4
10.8
657
5010
J45.8
ICD-10 Finland
Mixed asthma
2.1
10.8
118
566
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
10.7
307
2015
M13.8
ICD-10 Finland
Other specified arthritis
3.8
10.7
44
117
130
Kela drug reimbursment
Malignant tumour
0.6
10.7
147
2466
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
10.7
280
1799
A01AB04
ATC
amphotericin B; local oral
1.7
10.6
230
1404
JN4BD
NOMESCO Finland
Extensive body CT
1.4
10.6
451
3227
L04AB01
ATC
etanercept; parenteral
3.6
10.5
46
129
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
10.5
863
6882
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.5
10.5
416
2929
ZXA00
NOMESCO Finland
Right side
1.3
10.5
1182
9831
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
10.5
85
356
J01MA01
ATC
ofloxacin; systemic
1.5
10.4
370
2550
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.6
10.4
293
1913
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
110.2
10.4
11
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
10.4
10
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.0
10.4
127
638
ZZA00
NOMESCO Finland
Split skin graft
2.0
10.4
134
691
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.6
10.4
247
1547
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
4.3
10.3
37
87
R81
ICPC
Pneumonia
2.0
10.3
131
670
SPAT1359
SPAT
Use of symptom diary
2.2
10.3
101
464
VALMI
NOMESCO Finland
NA
1.3
10.3
701
5434
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
1.7
10.3
233
1436
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
10.3
409
2886
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
10.3
346
2357
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
10.3
548
4087
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
5.3
10.2
30
57
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.7
10.2
192
1125
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
3.1
10.2
53
170
XF402
NOMESCO Finland
ECG with work load test
1.4
10.2
476
3464
9211
FHL
Exploration or removal of diskusprolapse
2.1
10.1
105
495
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
10.1
560
4200
A99
ICPC
Disease/condition unspecnature/site
1.5
10.1
313
2091
R4180
NOMESCO Finland
Podiatric therapy
3.3
10.1
49
150
J01EA01
ATC
trimethoprim; systemic
1.3
10.0
1102
9131
R01AD12
ATC
fluticasone furoate; nasal
1.3
10.0
787
6232
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.7
10.0
186
1084
UKC02
NOMESCO Finland
Cystoscopy
1.3
10.0
711
5547
M54.3
ICD-10 Finland
Sciatica
1.7
10.0
214
1303
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
10.0
554
4155
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.9
9.9
132
688
R96
ICPC
Asthma
1.5
9.8
331
2254
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.3
9.8
91
407
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
9.7
285
1879
D07AC13
ATC
mometasone; topical
1.3
9.7
1040
8589
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
9.7
967
7912
C03DA01
ATC
spironolactone; oral
1.4
9.7
500
3706
SPAT1312
SPAT
General health counselling
1.3
9.6
1158
9692
SPAT1131
SPAT
Colonoscopy
1.9
9.6
137
732
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.8
9.5
151
838
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.0
9.5
116
583
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.2
9.5
93
428
S86.0
ICD-10 Finland
Injury of Achilles tendon
2.3
9.5
82
356
R04.2
ICD-10 Finland
Haemoptysis
1.9
9.5
143
781
M54.6
ICD-10 Finland
Pain in thoracic spine
1.7
9.5
200
1211
SPAT1104
SPAT
Monitoring of emergency patient
1.6
9.5
270
1769
B01AC04
ATC
clopidogrel; oral
1.3
9.5
736
5818
R35
ICD-10 Finland
Polyuria
1.6
9.5
247
1587
5BA08
NOMESCO Finland
NA
4.2
9.4
34
81
M11.2
ICD-10 Finland
Other chondrocalcinosis
4.2
9.4
34
81
Z02.4
ICD-10 Finland
Examination for driving licence
1.3
9.4
1021
8436
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
2.4
9.4
74
305
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
9.4
9
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
9.4
9
*
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
9.4
9
*
44630
ICD-8 Finland
Polyarteritis nodosa and allied conditions, Arteritis cranialis (temporalis)
+∞
9.4
9
*
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
9.4
189
1133
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
9.3
207
1270
C09CA01
ATC
losartan; oral
1.3
9.3
1039
8611
B02.9
ICD-10 Finland
Zoster without complication
1.6
9.3
244
1568
R15
ICD-10 Finland
Faecal incontinence
1.9
9.3
127
667
R01AD01
ATC
beclometasone; nasal
1.4
9.3
496
3694
R06.2
ICD-10 Finland
Wheezing
1.8
9.3
154
867
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.1
9.2
98
467
M15.8
ICD-10 Finland
Other polyarthrosis
2.3
9.2
82
361
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
9.2
2376
21562
-34
ICPC
Blood test
2.0
9.2
120
623
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
9.1
439
3215
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
9.0
372
2643
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.7
9.0
172
1015
XCK00
NOMESCO Finland
Perimetry
1.5
9.0
292
1975
D02AE01
ATC
carbamide; topical
1.6
9.0
229
1463
R29
ICPC
Respiratory symptom/complaint other
1.6
9.0
205
1273
D19
ICPC
Teeth/gum symptom/complaint
1.3
8.9
730
5810
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
8.9
736
5864
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
8.8
1902
16925
M70.2
ICD-10 Finland
Olecranon bursitis
1.9
8.8
117
609
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
8.8
693
5485
R03BA01
ATC
beclometasone; inhalant
1.4
8.8
518
3925
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.5
8.8
64
255
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.0
8.8
104
521
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
2.2
8.7
85
392
M12.3
ICD-10 Finland
Palindromic rheumatism
7.2
8.7
20
28
R11
ICD-10 Finland
Nausea and vomiting
1.5
8.7
310
2139
M10.0
ICD-10 Finland
Idiopathic gout
1.8
8.7
136
753
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.7
8.7
36
98
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
50.1
8.7
10
*
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
8.7
1549
13523
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
8.6
386
2787
N06AB10
ATC
escitalopram; oral
1.4
8.6
530
4041
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
7.6
8.6
19
25
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
8.6
201
1257
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.6
8.5
194
1200
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.4
8.5
392
2846
C08CA05
ATC
nifedipine; systemic
1.5
8.5
290
1986
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.8
8.5
145
825
L90
ICPC
Osteoarthrosis of knee
1.5
8.5
265
1779
C09AA05
ATC
ramipril; oral
1.2
8.5
1145
9694
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
8.5
140
792
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.4
8.4
71
304
D01BA02
ATC
terbinafine; oral; topical
1.3
8.4
900
7409
J02AC02
ATC
itraconazole; systemic
1.3
8.4
617
4833
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
6.0
8.4
22
37
S29
ICPC
Skin symptom/complaint other
1.3
8.4
628
4931
L02
ICPC
Back symptom/complaint
1.5
8.4
279
1898
H13
ICPC
Plugged feeling ear
1.3
8.4
746
6003
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.6
8.4
186
1147
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
8.3
924
7642
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.5
8.3
256
1710
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
8.3
288
1978
M75.5
ICD-10 Finland
Bursitis of shoulder
2.2
8.3
84
394
J05AB11
ATC
valaciclovir; oral
1.4
8.3
450
3360
R01AD11
ATC
triamcinolone; nasal
1.5
8.3
283
1934
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
1.5
8.3
320
2244
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
8.3
751
6060
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
2.3
8.2
71
310
B01AE07
ATC
dabigatran etexilate; oral
1.7
8.2
178
1090
M54.8
ICD-10 Finland
Other dorsalgia
1.8
8.2
132
739
C10AA04
ATC
fluvastatin; oral
1.4
8.2
437
3256
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
8.2
202
1280
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
8.2
1129
9575
R52.0
ICD-10 Finland
Acute pain
2.0
8.2
95
472
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.1
8.2
85
401
SPAT1202
SPAT
Intra-articular injection
1.7
8.2
150
876
N06AB04
ATC
citalopram; systemic
1.3
8.2
779
6324
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
8.1
371
2689
H26.3
ICD-10 Finland
Drug-induced cataract
4.1
8.1
30
74
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.7
8.1
53
199
A10BA02
ATC
metformin; oral
1.2
8.1
1191
10166
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.8
8.1
48
170
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.3
8.1
718
5770
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.5
8.1
304
2123
C10AA03
ATC
pravastatin; oral
1.4
8.1
329
2335
M35
ICD-10 Finland
Other systemic involvement of connective tissue
33.4
8.1
10
*
A03FA02
ATC
cisapride; oral, rectal
1.4
8.0
349
2504
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.1
8.0
89
433
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
8.0
827
6774
G04BD08
ATC
solifenacin; oral
1.5
8.0
303
2117
K30
ICD-10 Finland
Functional dyspepsia
1.4
8.0
351
2526
A02BA04
ATC
nizatidine; systemic
1.4
8.0
355
2562
C08CA13
ATC
lercanidipine; oral
1.3
8.0
593
4654
A97
ICPC
No disease
1.3
7.9
519
3993
M01AX01
ATC
nabumetone; oral
1.6
7.9
183
1140
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.5
7.9
289
2007
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
7.9
168
1024
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
7.9
246
1650
H25.0
ICD-10 Finland
Senile incipient cataract
1.5
7.9
281
1942
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
7.9
363
2638
S06
ICPC
Rash localized
1.6
7.9
205
1320
M66.0
ICD-10 Finland
Rupture of popliteal cyst
2.5
7.8
59
241
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
7.8
843
6941
NA3CM
NOMESCO Finland
Lumbar spine extensive MRI examination with 3 Tesla magnet
5.1
7.8
23
45
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
7.8
1013
8524
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
7.8
129
730
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.5
7.8
273
1876
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.6
7.8
218
1423
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
7.8
254
1721
B82
ICPC
Anaemia other/unspecified
1.9
7.8
101
526
7290A
ICD-9 Finland
Other disorders of soft tissues, Rheumatism, unspecified and fibrositis
3.4
7.8
35
103
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
7.7
727
5883
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.3
7.7
37
114
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
7.7
171
1054
R1250
NOMESCO Finland
Evaluation of functional capability
2.2
7.7
75
347
J45.1
ICD-10 Finland
Nonallergic asthma
1.5
7.7
253
1717
PAA99
NOMESCO Finland
Exploration of other arterial branch originating from aortic arch arteries
15.0
7.7
12
8
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
7.7
241
1617
A10AE04
ATC
insulin glargine; parenteral
1.4
7.7
355
2576
H57.1
ICD-10 Finland
Ocular pain
1.9
7.7
100
522
SBA10
NOMESCO Finland
Measurement of excretion of saliva
3.5
7.7
34
99
M01AE52
ATC
naproxen and esomeprazole; oral
1.9
7.7
104
551
XF600
NOMESCO Finland
Bloodpressure measurement
1.5
7.6
233
1555
R03AC13
ATC
formoterol; inhalant
1.6
7.6
185
1170
M25.9
ICD-10 Finland
Joint disorder, unspecified
3.3
7.6
36
110
R03AK08
ATC
formoterol and beclometasone; inhalant
1.8
7.6
121
676
R74
ICPC
Upper respiratory infection acute
1.3
7.6
656
5250
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
2.1
7.6
81
388
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
7.6
1009
8513
RF210
NOMESCO Finland
NA
2.0
7.6
97
502
N05BA12
ATC
alprazolam; oral
1.4
7.6
347
2518
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
7.6
183
1156
K07
ICPC
Swollen ankles/oedema
1.6
7.6
205
1333
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
1.8
7.6
115
633
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
7.6
786
6444
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
7.5
277
1924
XQ800
NOMESCO Finland
Prick test
1.6
7.5
176
1102
M77.9
ICD-10 Finland
Enthesopathy, unspecified
2.1
7.5
83
404
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.8
7.5
124
701
M15
ICD-10 Finland
Polyarthrosis
1.5
7.5
215
1416
N06AX16
ATC
venlafaxine; oral
1.4
7.5
354
2582
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
7.5
243
1644
K78
ICPC
Atrial fibrillation/flutter
1.4
7.5
388
2876
H02BX01
ATC
methylprednisolone, combinations; systemic
1.5
7.5
240
1623
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
7.5
266
1839
D07AD01
ATC
clobetasol; topical
1.3
7.4
526
4096
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
7.4
203
1322
SPAT1281
SPAT
Other administrative function
1.5
7.4
274
1909
E87.6
ICD-10 Finland
Hypokalaemia
1.8
7.4
125
714
JN4AD
NOMESCO Finland
Body CT examination
1.4
7.4
289
2034
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
7.4
171
1070
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.9
7.4
95
493
R4120
NOMESCO Finland
Occupational therapy
1.5
7.4
207
1357
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
7.3
250
1711
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.8
7.3
113
626
S70.0
ICD-10 Finland
Contusion of hip
1.6
7.3
159
977
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.9
7.3
101
538
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
7.3
7
*
4AC0S
NOMESCO Finland
NA
+∞
7.3
7
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.4
7.3
384
2853
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
7.3
893
7461
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.7
7.3
150
908
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
7.3
447
3407
R63.4
ICD-10 Finland
Abnormal weight loss
1.7
7.2
138
818
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
3.3
7.2
34
104
Z02.7
ICD-10 Finland
Issue of medical certificate
1.5
7.2
213
1410
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
7.2
294
2087
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
7.2
449
3427
R78
ICPC
Acute bronchitis/bronchiolitis
2.0
7.2
85
425
A10BH01
ATC
sitagliptin; oral
1.4
7.2
389
2906
NG2AA
NOMESCO Finland
Patella X-ray examination
1.8
7.2
108
595
D82
ICPC
Teeth/gum disease
1.2
7.2
944
7954
L16
ICPC
Ankle symptom/complaint
1.4
7.1
323
2340
C09CA06
ATC
candesartan; oral
1.3
7.1
782
6451
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
2.8
7.1
43
156
D07AB08
ATC
desonide; topical
1.4
7.1
348
2555
R51
ICD-10 Finland
Headache
1.7
7.1
133
785
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.7
7.1
140
839
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.6
7.1
163
1017
TGC00
NOMESCO Finland
Bronchial lavation
1.9
7.1
97
516
H92.0
ICD-10 Finland
Otalgia
1.7
7.1
141
844
M02.8
ICD-10 Finland
Other reactive arthropathies
5.3
7.1
20
38
N05BA04
ATC
oxazepam; oral
1.2
7.0
921
7749
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
1.7
7.0
127
740
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
7.0
546
4307
RF410
NOMESCO Finland
NA
2.6
7.0
49
191
J01FA15
ATC
telithromycin; oral
1.4
7.0
298
2135
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.7
7.0
125
727
K29.7
ICD-10 Finland
Gastritis, unspecified
1.7
7.0
132
780
H15.1
ICD-10 Finland
Episcleritis
2.7
7.0
43
158
Z00.8
ICD-10 Finland
Other general examinations
1.5
7.0
224
1516
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.6
7.0
162
1012
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.5
7.0
264
1847
R06AE09
ATC
levocetirizine; oral
1.4
7.0
387
2903
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
7.0
345
2541
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.7
7.0
126
733
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.5
6.9
52
211
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
1.9
6.9
90
471
M48.8
ICD-10 Finland
Other specified spondylopathies
5.1
6.9
20
39
NXL00
NOMESCO Finland
Biopsy of muscle
5.1
6.9
20
39
L50.9
ICD-10 Finland
Urticaria, unspecified
1.9
6.9
96
514
M75
ICD-10 Finland
Shoulder lesions
1.7
6.9
140
845
D01
ICPC
Abdominal pain/cramps general
1.4
6.9
313
2267
U02
ICPC
Urinary frequency/urgency
1.3
6.9
498
3888
M43.1
ICD-10 Finland
Spondylolisthesis
1.7
6.9
136
812
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.9
227
1543
A06AD11
ATC
lactulose; oral
1.3
6.9
688
5609
M01AC01
ATC
piroxicam; systemic, rectal
1.3
6.9
537
4240
A06AC51
ATC
ispaghula, combinations; systemic
1.6
6.8
186
1211
TQW80
NOMESCO Finland
Local dermatologic skincare
1.9
6.8
97
523
A91
ICPC
Abnormal result investigation NOS
1.6
6.8
157
979
M07.3
ICD-10 Finland
Other psoriatic arthropathies
2.8
6.8
40
142
G04BD04
ATC
oxybutynin; oral, transdermal
1.5
6.8
259
1816
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
1.7
6.8
121
701
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.8
6.8
103
570
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
6.8
205
1368
B35.1
ICD-10 Finland
Tinea unguium
1.6
6.8
176
1134
S80.0
ICD-10 Finland
Contusion of knee
1.5
6.8
187
1224
K07.60
ICD-10 Finland
Snapping jaw
1.8
6.8
99
541
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
40.1
6.8
8
*
L05
ICPC
Flank/axilla symptom/complaint
1.6
6.8
185
1207
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
1.9
6.7
100
545
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.5
6.7
188
1233
XCH00
NOMESCO Finland
Eye pressure measurement
1.6
6.7
161
1014
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.5
6.7
231
1587
R4110
SPAT
NA
1.8
6.7
104
578
M76.0
ICD-10 Finland
Gluteal tendinitis
2.3
6.7
60
268
A07EA06
ATC
budesonide; oral, local oral
1.9
6.7
92
490
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
6.7
383
2885
C07AA05
ATC
propranolol; systemic
1.3
6.7
578
4627
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.9
6.7
96
520
D05AX52
ATC
calcipotriol, combinations; topical
1.6
6.7
167
1065
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
6.7
420
3216
G62.8
ICD-10 Finland
Other specified polyneuropathies
3.2
6.7
32
100
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.2
6.7
65
303
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
2.0
6.6
83
426
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.4
6.6
257
1810
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
6.6
991
8454
G50.1
ICD-10 Finland
Atypical facial pain
2.3
6.6
56
242
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
6.6
276
1971
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.7
6.6
123
725
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
6.6
163
1040
A02BC04
ATC
rabeprazole; oral
1.4
6.6
263
1860
U04
ICPC
Incontinence urine
1.5
6.6
201
1344
PD5AD
NOMESCO Finland
CT of aorta
2.1
6.6
65
306
S22.3
ICD-10 Finland
Fracture of rib
1.5
6.6
223
1526
M01AB08
ATC
etodolac; oral
1.4
6.6
253
1776
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.1
6.6
67
319
L60.0
ICD-10 Finland
Ingrowing nail
1.6
6.6
140
859
R06AX13
ATC
loratadine; oral
1.3
6.5
414
3170
M25.3
ICD-10 Finland
Other instability of joint
8.7
6.5
13
15
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
6.5
71
345
F03
ICPC
Eye discharge
1.6
6.5
170
1094
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
6.5
279
2000
G04CA02
ATC
tamsulosin; oral
1.2
6.5
905
7660
J34.2
ICD-10 Finland
Deviated nasal septum
1.7
6.5
129
772
D11
ICPC
Diarrhoea
1.4
6.5
286
2063
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.5
6.5
211
1433
J01DA06
ATC
[U] cefuroxime; systemic
1.3
6.5
486
3813
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.3
6.5
609
4925
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.6
6.5
157
994
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
6.5
1132
9804
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.5
168
1084
R06AX27
ATC
desloratadine; oral
1.3
6.5
682
5595
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.0
6.5
80
412
B80
ICPC
Iron deficiency anaemia
2.1
6.5
71
349
E24.2
ICD-10 Finland
Drug-induced Cushing syndrome
69.9
6.4
7
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.8
6.4
107
610
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.6
6.4
150
943
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.6
6.4
148
924
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.3
6.4
390
2967
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.3
6.4
688
5657
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
6.4
237
1654
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
6.4
221
1519
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.4
6.4
28
82
D06
ICPC
Abdominal pain localized other
1.4
6.4
252
1782
RF420
NOMESCO Finland
NA
2.4
6.3
50
212
C01CA24
ATC
epinephrine; parenteral
1.7
6.3
129
779
A07EC02
ATC
mesalazine; oral, rectal
1.6
6.3
149
937
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.1
6.3
67
322
M01AE11
ATC
tiaprofenic acid; oral, rectal
1.5
6.3
180
1186
G72.9
ICD-10 Finland
Myopathy, unspecified
2.9
6.3
34
116
9243
FHL
Plastic of the patella and its tendons
3.4
6.3
28
83
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.3
160
1028
A11
ICPC
Chest pain NOS
1.4
6.3
295
2151
M65.3
ICD-10 Finland
Trigger finger
1.6
6.3
137
843
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.5
6.3
234
1633
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.6
6.3
137
844
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
3.1
6.3
32
105
M09AX01
ATC
hyaluronic acid; parenteral
1.4
6.3
238
1671
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
6.2
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
0.5
6.2
34
744
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.5
6.2
179
1181
9212
FHL
Other posterior root decompression surgery (eg laminectomy, Gill)
2.5
6.2
45
182
L84
ICPC
Back syndrome without radiat pain
1.6
6.2
146
917
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.4
6.2
310
2287
Z50.1
ICD-10 Finland
Other physical therapy
1.5
6.2
213
1464
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
1.8
6.2
98
551
E000003
ATC
NA
1.6
6.2
136
840
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.5
6.2
207
1417
S76
ICPC
Skin infection other
1.5
6.2
174
1146
M01AB51
ATC
indometacin, combinations; oral, rectal
1.8
6.2
90
493
R32
ICD-10 Finland
Unspecified urinary incontinence
1.7
6.1
117
694
-50
ICPC
Medication/prescr/renewal
1.6
6.1
163
1059
C05AA08
ATC
fluocortolone; rectal, topical
1.3
6.1
508
4043
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.0
6.1
71
357
SPAT1360
SPAT
Extensive global examination
1.4
6.1
302
2220
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.1
6.1
64
309
H19.3
ICD-10 Finland
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
7.7
6.1
13
17
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.0
6.1
71
358
SPAT1081
SPAT
Cardiorespiratory global assessment
1.4
6.1
243
1719
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.5
6.1
194
1313
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
12.5
6.1
10
8
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.4
6.1
300
2211
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
6.1
304
2246
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
1.8
6.0
91
504
115
Kela drug reimbursment
Breast cancer
0.7
6.0
160
2329
SPAT1283
SPAT
Restricted health certificate
1.4
6.0
231
1625
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
3.3
6.0
27
81
A03CA02
ATC
clidinium and psycholeptics; oral
1.4
6.0
268
1940
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002030) Lymphocytes/100 leukocytes in Blood
3332
19181
3.09
321.44
9.5
5.6
%
24.0
26.3
29.03
3161
17479
(3018010) Neutrophils/100 leukocytes in Blood
3281
18876
3.03
313.96
9.1
5.4
%
61.6
58.4
39.63
3117
17283
(3022096) Basophils/100 leukocytes in Blood
3272
18254
3.17
307.65
9.2
5.4
%
0.6
0.7
6.71
3120
16708
(3006504) Eosinophils/100 leukocytes in Blood
3309
18759
3.14
307.65
9.2
5.4
%
2.3
2.8
35.34
3153
17153
(3019198) Lymphocytes [#/volume] in Blood
3578
20372
3.48
307.65
8.9
5.2
e9/l
1.8
1.9
1.28
3252
17419
(3006315) Basophils [#/volume] in Blood
3574
20007
3.57
307.65
8.8
5.1
e9/l
0.0
0.0
1.50
3211
16824
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2260
5446
6.61
307.65
1.5
1.2
u/ml
10.5
14.7
0.89
851
1872
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2252
5812
6.11
307.65
1.5
1.2
iu/ml
33.0
40.3
1.11
728
1768
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
649
1246
5.82
307.65
1.8
1.4
titre
381.5
255.5
0.46
40
53
(3019069) Monocytes/100 leukocytes in Blood
3322
18858
3.15
307.65
9.6
5.7
%
8.5
8.9
9.43
3162
17294
(3013115) Eosinophils [#/volume] in Blood
3617
20673
3.52
307.65
9.0
5.3
e9/l
0.2
0.2
13.08
3277
17641
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2909
14090
3.45
307.65
2.6
2.1
u/l
124.9
208.2
12.37
2726
13024
(3001604) Monocytes [#/volume] in Blood
3556
19880
3.55
307.65
8.7
5.1
e9/l
0.6
0.6
4.89
3194
16696
(3009445) Proteinase 3 Ab [Units/volume] in Serum
865
1586
6.35
307.65
1.7
1.1
u/ml
19.5
3.9
2.04
19
17
(3020630) Protein [Mass/volume] in Serum or Plasma
1276
4142
3.77
307.65
2.1
2.6
g/l
66.1
65.9
0.31
1141
3661
(3004588) Protein electrophoresis panel - Serum or Plasma
1209
3444
4.28
307.65
2.0
2.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1793
4235
5.96
307.65
1.5
1.2
titre
467.5
426.3
0.52
437
866
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
529
882
6.57
307.57
1.9
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
590
1152
5.65
290.91
1.3
1.2
u/ml
0.5
0.7
0.26
75
118
(3013650) Neutrophils [#/volume] in Blood by Automated count
3735
23622
3.12
290.75
11.2
8.4
e9/l
4.9
4.2
48.55
3375
20276
(3013707) Erythrocyte sedimentation rate by Westergren method
4381
30706
3.86
280.68
12.7
3.9
mm/h
17.5
14.7
22.76
4178
27803
(42870588) Differential panel, method unspecified - Blood
2616
14138
2.73
267.39
8.2
5.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
518
1008
5.60
255.49
1.5
1.2
iu/ml
13.6
8.3
—
15
8
(3026493) Urate [Moles/volume] in Serum or Plasma
2194
11102
2.70
252.05
2.7
2.8
umol/l
3226.0
6840.9
4.21
1912
9221
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3013
17822
2.66
251.15
2.7
2.2
nmol/l
82.5
80.0
5.21
2718
15359
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
466
914
5.51
227.26
1.6
1.6
iu/ml
6.0
7.4
0.06
106
208
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
419
746
6.03
226.61
1.4
1.1
titre
176.7
31.4
—
12
7
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3551
23765
2.59
213.19
7.3
6.4
mmol/l
1.2
1.2
5.86
3024
19732
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
397
712
5.96
212.86
1.3
1.1
u/ml
7.8
4.4
0.65
78
84
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
410
764
5.74
211.09
1.3
1.1
u/ml
34.9
44.1
0.17
19
27
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
392
703
5.95
210.15
1.3
1.1
u/ml
3.0
3.2
0.08
53
45
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
356
599
6.31
203.60
1.3
1.1
u/ml
1.8
4.2
0.41
33
29
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
423
845
5.36
201.64
1.6
1.2
g/l
0.2
0.2
1.22
400
789
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
351
588
6.33
201.60
1.4
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
429
873
5.27
200.24
1.6
1.2
g/l
1.2
1.2
1.12
408
816
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
652
1922
3.74
187.96
1.7
2.3
g/l
8.2
7.5
12.62
457
1382
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
651
1919
3.74
187.67
1.7
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
650
1918
3.73
187.07
1.7
2.3
g/l
3.8
3.8
0.28
446
1321
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
714
2290
3.46
180.70
2.6
2.4
au/ml
39.5
23.6
0.93
19
74
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
184
165
11.53
176.04
1.5
1.2
u/l
5.2
6.5
0.61
152
139
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
603
1771
3.72
174.27
1.8
2.4
g/l
3.5
3.1
8.98
454
1350
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
470
1168
4.33
171.31
1.7
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
606
1808
3.67
170.97
1.7
2.4
g/l
9.5
10.3
3.56
500
1477
(3037467) Urinalysis macro (dipstick) panel - Urine
3986
29536
2.55
170.51
7.2
4.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3177
21528
2.24
164.88
6.5
5.7
mmol/l
1.2
1.2
3.37
2930
19159
(3004616) Nuclear Ab [Presence] in Serum
256
382
7.00
164.00
1.4
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
642
2052
3.43
162.59
1.4
1.3
au/ml
58.1
59.0
0.02
12
98
(3017181) Myelocytes/100 leukocytes in Blood
896
3497
2.89
161.13
5.9
3.8
%
0.9
0.9
0.19
284
1040
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4279
33168
2.72
159.77
10.3
7.3
u/l
74.8
81.4
19.12
4103
30803
(40760892) CBC W Ordered Manual Differential panel - Blood
1546
7904
2.37
158.75
7.1
4.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
884
3456
2.88
158.27
1.9
2.1
nmol/l
338.1
384.8
7.01
816
3085
(3000475) Leukocytes [#/volume] in Synovial fluid
426
1065
4.27
153.68
1.9
1.6
e6/l
11569.7
14729.5
0.87
337
747
(3008898) HLA-B27 [Presence]
342
722
5.00
152.30
1.1
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
851
3325
2.87
152.12
6.1
3.8
%
0.1
0.1
2.25
269
968
(3025159) Blasts/100 leukocytes in Blood
807
3103
2.90
148.36
6.2
3.8
%
0.1
0.4
1.50
233
807
(3002179) Metamyelocytes/100 leukocytes in Blood
813
3160
2.87
146.37
5.7
3.6
%
0.4
0.7
2.41
214
726
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
536
1638
3.54
144.97
1.9
2.4
g/l
0.7
1.1
1.96
448
1356
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
498
1501
3.57
137.35
1.7
2.2
g/l
35.7
37.2
5.50
405
1238
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
478
1412
3.63
135.88
1.8
2.3
g/l
0.0
0.1
2.57
423
1260
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
530
1692
3.38
133.49
2.3
3.3
mg/l
35.3
57.0
1.64
410
1368
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
519
1647
3.39
131.93
2.3
3.2
ratio
2.9
2.4
0.16
60
112
(3034860) Kappa light chains.free [Mass/volume] in Serum
528
1695
3.36
131.75
2.3
3.3
mg/l
49.9
92.9
0.68
405
1370
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2014
12230
2.06
128.73
2.7
2.3
mg/l
3.2
3.1
0.26
1702
10309
(3005719) IgG [Mass/volume] in Serum or Plasma
688
2615
2.88
128.14
2.8
2.6
g/l
10.1
10.6
2.33
644
2349
(3023368) Bacteria identified in Blood by Culture
2175
13598
2.04
128.10
5.2
4.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2931
20647
1.97
119.71
5.6
4.2
estimate
0.0
0.0
0.00
690
3775
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
254
511
5.18
119.28
1.8
1.4
%
51.4
62.9
4.01
171
320
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
465
1471
3.38
118.42
1.4
1.8
u/l
34.0
38.4
5.00
409
1244
(3044927) Protein electrophoresis panel - Urine
250
500
5.20
118.18
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
384
1080
3.76
116.98
1.4
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
432
1322
3.48
115.86
1.8
2.3
g/l
0.0
0.0
0.00
381
1176
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2468
16526
1.95
115.66
3.4
2.8
ug/l
168.3
147.9
1.30
2226
14807
(3009261) Glucose [Presence] in Urine by Test strip
2948
20951
1.95
115.64
5.7
4.2
estimate
0.0
0.0
1.08
678
3713
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
426
1295
3.50
115.43
1.8
2.3
g/l
0.0
0.0
0.00
380
1173
(3021601) Nitrite [Presence] in Urine by Test strip
2915
20695
1.94
114.05
7.3
5.6
estimate
0.0
0.0
0.00
692
3757
(40760888) Immunoglobulin light chains.free panel - Serum
417
1261
3.51
113.88
2.3
3.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
568
2068
2.96
113.83
1.7
1.9
g/l
1.4
1.4
0.09
521
1830
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
136
148
9.41
113.31
1.2
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1352
7383
2.13
111.95
2.5
2.4
umol/l
11.2
12.0
3.45
1230
6738
(3038026) Centromere Ab [Units/volume] in Serum
175
265
6.80
110.32
1.4
1.1
u/ml
79.0
34.5
—
6
7
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
468
1591
3.14
105.49
1.9
2.1
ug/l
260.6
681.3
2.32
417
1500
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
169
262
6.64
104.16
1.4
1.1
u/ml
39.5
50.7
0.13
11
11
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
168
260
6.65
103.72
1.4
1.1
u/ml
30.8
69.0
—
5
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
162
243
6.85
103.01
1.4
1.1
u/ml
3.8
6.3
—
13
7
(3018418) pH of Serum or Plasma
2157
14207
1.89
102.44
4.3
3.9
ph
7.4
7.4
2.14
443
2671
(3021589) Normoblasts [#/volume] in Blood
2543
17675
1.87
101.73
15.2
10.0
e9/l
0.0
0.0
0.19
2172
14302
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
236
516
4.75
100.34
1.3
1.1
u/ml
52.9
35.5
0.56
19
44
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1185
6437
2.09
97.68
2.6
2.5
%
20.4
21.2
1.21
987
5362
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1237
6848
2.06
96.76
2.5
2.4
g/l
2.2
2.3
2.60
1131
6242
(3021788) Differential panel - Synovial fluid
290
782
3.87
93.55
1.6
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
134
182
7.53
93.20
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
134
182
7.53
93.20
1.3
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
179
328
5.62
93.09
1.2
1.1
u/ml
28.4
52.8
—
14
8
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
134
183
7.49
92.75
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
134
185
7.41
91.86
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
134
185
7.41
91.86
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
134
185
7.41
91.86
1.3
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3689
29427
1.89
89.20
6.7
5.3
e6/l
611.7
2761.2
4.45
61
485
(3024561) Albumin [Mass/volume] in Serum or Plasma
2764
20277
1.78
87.39
4.6
4.5
g/l
33.8
34.6
10.39
2535
18531
(3023420) DNA double strand Ab [Units/volume] in Serum
162
287
5.80
87.30
1.6
1.1
iu/ml
25.9
27.3
—
12
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
85
68
12.69
87.20
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
85
68
12.69
87.20
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
85
68
12.69
87.20
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
85
68
12.69
87.20
1.1
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
309
916
3.52
86.59
1.4
1.9
mg/l
10.8
12.1
1.49
279
835
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1030
5526
2.08
86.56
2.9
3.9
u/l
241.1
248.4
0.84
940
5150
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4616
40120
2.45
85.48
31.9
16.7
mg/l
23.4
26.5
10.10
4375
32717
(3027945) Reticulocytes/100 erythrocytes in Blood
1064
5884
2.02
81.77
2.3
2.3
%
1.8
1.8
0.49
923
5108
(3018095) Leukocytes [#/volume] in Urine
2271
15955
1.76
81.40
4.8
3.8
e6/l
88.1
127.0
1.95
1729
11486
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
505
2051
2.62
81.11
2.0
1.8
ug/l
1.1
2.4
2.84
429
1755
(3007164) IgA [Mass/volume] in Serum or Plasma
1123
6349
1.98
80.95
1.6
1.5
g/l
2.6
2.7
0.26
714
3454
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
184
392
4.83
80.63
1.7
1.4
%
35.9
29.6
1.31
127
246
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2255
15950
1.74
77.81
3.7
3.1
ng/l
1694.9
1791.0
0.51
1988
13784
(3010144) Erythrocytes [#/volume] in Synovial fluid
186
415
4.61
77.04
1.6
1.3
e6/l
49479.9
156407.3
1.54
129
291
(3013826) Glucose [Moles/volume] in Serum or Plasma
3339
26389
1.75
76.59
5.5
4.6
mmol/l
6.9
6.9
0.05
3183
24761
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1324
8161
1.84
72.13
2.1
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
837
4444
2.05
71.05
2.3
2.4
e9/l
67.7
68.5
0.30
653
3371
(3015377) Calcium [Moles/volume] in Serum or Plasma
2229
16063
1.68
69.21
3.0
3.3
mmol/l
2.4
2.4
0.58
1869
13558
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2978
23165
1.68
68.73
5.5
5.9
umol/l
10.5
12.0
14.69
2814
21821
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1976
13821
1.70
68.45
2.7
2.5
u/l
59.4
58.1
0.26
1797
12597
(3002582) Erythrocytes [#/volume] in Urine
1987
13959
1.69
67.44
4.0
3.3
e6/l
57.2
85.5
0.78
1630
10737
(46235355) HIV 1 and 2 tests - Meaningful Use set
656
3260
2.16
65.99
1.4
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1745
11927
1.70
65.06
1.7
1.6
nmol/l
19.6
20.5
1.71
1470
9984
(3017732) Neutrophils [#/volume] in Blood
547
2560
2.27
63.71
3.7
3.3
e9/l
4.7
4.2
3.32
360
1808
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3684
30628
1.71
63.16
4.6
4.1
pmol/l
15.2
15.1
1.14
3296
27012
(3024980) IgG subclass 4 [Mass/volume] in Serum
176
442
4.09
62.52
1.5
1.5
g/l
0.7
0.8
0.46
138
330
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2629
20104
1.63
62.27
2.4
2.1
pmol/l
96.1
93.9
1.45
1428
10025
(3030467) Casts [#/volume] in Urine by Automated count
1817
12820
1.64
58.45
3.9
3.2
e6/l
0.4
0.5
1.79
1471
9736
(3000850) Epithelial cells [#/volume] in Urine
1480
9908
1.69
58.29
3.1
2.6
e6/l
4.9
5.4
0.97
1330
8621
(3042936) Bacteria identified in Isolate by Culture
1027
6207
1.82
57.96
2.2
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2143
15796
1.61
57.42
6.4
4.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
374
1555
2.52
56.66
2.4
2.8
g/l
0.2
0.3
0.99
138
564
(36304419) Bacteria [Presence] in Urine
1751
12314
1.64
56.63
3.9
3.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1650
11448
1.65
56.22
6.5
4.6
estimate
0.0
0.0
0.88
685
3605
(3017143) Hepatitis C virus Ab [Presence] in Serum
567
2847
2.11
55.02
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
219
696
3.24
54.74
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4211
36883
1.78
53.77
5.8
5.0
mu/l
2.0
2.1
1.50
3826
32759
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
577
2964
2.07
52.59
1.3
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2400
18463
1.56
51.69
5.4
4.1
ng/l
187.7
54.1
0.70
1945
14228
(40758558) Short blood count panel - Blood
1507
10402
1.63
51.47
7.7
6.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1317
8856
1.65
49.57
1.8
1.7
mg/l
1.4
1.4
0.06
1055
6924
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2413
18726
1.54
49.03
2.5
2.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1509
10586
1.60
47.46
5.5
4.0
—
—
—
0
0
(3019225) pH of Specimen
827
4948
1.80
47.31
5.1
4.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
60
71
8.54
46.79
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1495
10495
1.60
46.74
2.0
1.8
nmol/l
1196.6
1176.0
0.35
1138
7661
(40768797) Stomach Pathology biopsy report
922
5753
1.73
45.44
1.3
1.3
—
—
—
0
0
(4062490)
119
284
4.27
45.26
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4247
37806
1.70
44.75
7.8
6.5
mmol/mol
41.8
40.9
7.77
3903
33982
(3032080) INR in Blood by Coagulation assay
2504
19831
1.51
44.71
12.2
10.8
inr
1.3
1.3
0.35
730
5361
(3034891) Synovial lining cells/100 cells in Synovial fluid
95
192
5.02
44.31
1.7
1.3
%
5.4
3.3
0.65
23
41
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
107
240
4.53
44.05
1.2
1.1
titre
336.8
112.6
1.41
25
34
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4209
37490
1.67
42.90
23.7
16.3
ml/min/173m2
71.1
72.0
2.13
3738
30944
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2848
23300
1.50
42.54
3.5
3.1
u/l
58.8
54.2
1.24
2568
20906
(3027135) IgG subclass 1 [Mass/volume] in Serum
115
281
4.16
42.41
1.5
1.3
g/l
6.9
6.9
0.00
88
198
(3028192) IgG subclass 2 [Mass/volume] in Serum
115
281
4.16
42.41
1.5
1.3
g/l
2.9
2.9
0.01
88
200
(3024139) IgG subclass 3 [Mass/volume] in Serum
115
281
4.16
42.41
1.5
1.3
g/l
0.4
0.4
0.32
88
200
(3021879) Hepatitis B virus core Ab [Presence] in Serum
377
1792
2.19
41.74
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
631
3611
1.85
41.38
1.9
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2081
16110
1.49
39.97
4.3
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
522
2853
1.92
39.37
3.9
3.6
mmol/l
2.1
2.1
0.09
384
2103
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1152
7877
1.60
39.07
3.3
2.9
e6/l
1.3
1.6
0.40
736
4498
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
542
3008
1.90
39.01
4.0
3.6
kpa
5.1
5.2
0.48
487
2737
(3019550) Sodium [Moles/volume] in Serum or Plasma
4611
42375
1.84
38.92
28.9
20.3
mmol/l
139.6
139.6
0.07
4520
41171
(3009343) pH of Capillary blood
536
2968
1.90
38.84
4.0
3.6
ph
7.4
7.4
0.66
58
375
(3023103) Potassium [Moles/volume] in Serum or Plasma
4615
42441
1.84
38.61
29.2
20.5
mmol/l
4.0
4.0
9.36
4520
41176
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
169
573
3.02
37.85
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
877
5657
1.66
37.49
2.0
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1414
10208
1.53
37.45
5.4
4.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
201
754
2.73
37.38
4.2
3.5
%
61.3
58.7
1.58
201
754
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
454
2410
1.97
37.25
1.7
1.6
g/l
1.8
1.5
7.08
380
2029
(3017704) Immunofixation for Urine
103
257
4.07
36.97
1.4
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
917
6011
1.64
36.72
4.6
5.1
mmol/l
1.0
1.0
0.12
840
5484
(3048689) Calprotectin [Mass/mass] in Stool
652
3916
1.76
36.11
2.0
1.9
ug/g
204.1
163.0
1.23
510
2957
(3026782) Osmolality of Urine
1315
9413
1.53
35.97
3.4
2.8
mosm/kgh2o
519.0
539.1
3.05
1143
7933
(3007853) Bacteria identified in Skin by Aerobe culture
789
5019
1.68
35.40
2.0
1.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
114
316
3.67
35.29
1.3
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
865
5643
1.64
35.16
2.0
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4568
42105
1.75
34.87
17.5
11.0
u/l
23.6
24.3
1.86
4440
40042
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1077
7424
1.57
34.73
1.3
1.2
u/ml
1.1
1.6
1.67
263
1831
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2435
19839
1.43
33.80
4.7
4.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
632
3841
1.74
33.43
3.2
3.4
ng/l
82.1
94.3
3.08
532
3146
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
354
1788
2.05
33.32
4.4
4.0
mmol/l
25.1
25.0
0.38
305
1599
(40761511) CBC panel - Blood by Automated count
4441
40746
1.65
32.98
25.3
16.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
537
3141
1.79
32.39
1.8
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
661
4103
1.70
32.32
4.1
3.9
mmol/l
1.2
1.2
0.16
598
3533
(3004809) Band form neutrophils/100 leukocytes in Blood
195
776
2.57
32.24
3.3
3.8
%
1.3
1.7
0.82
157
583
(3022313) Gas panel - Capillary blood
396
2107
1.95
32.16
4.1
3.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1044
7302
1.54
31.11
31.4
29.6
inr
1.4
1.5
0.35
157
966
(3010813) Leukocytes [#/volume] in Blood
4648
43313
1.75
30.69
41.0
25.0
e9/l
7.7
6.8
102.88
4548
41668
(3007461) Platelets [#/volume] in Blood
4646
43296
1.75
30.58
41.0
24.9
e9/l
258.7
243.4
42.16
4560
41845
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1283
9401
1.49
30.52
3.0
3.1
mmol/l
2.5
2.5
1.75
1110
8138
(3024731) MCV [Entitic volume]
4646
43301
1.75
30.50
40.9
24.9
fl
92.2
91.7
11.45
4592
42366
(3035941) MCH [Entitic mass]
4646
43302
1.75
30.48
40.8
24.8
pg
30.3
30.4
3.77
4592
42367
(3026361) Erythrocytes [#/volume] in Blood
4646
43303
1.75
30.47
41.0
25.0
e12/l
4.3
4.4
27.84
4543
41667
(3000963) Hemoglobin [Mass/volume] in Blood
4646
43314
1.74
30.29
41.3
25.1
g/l
128.5
131.8
45.28
4590
42404
(3017354) Segmented neutrophils/100 leukocytes in Blood
137
471
2.96
29.98
3.1
3.8
%
62.3
57.8
1.41
93
290
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1038
7329
1.52
29.40
3.6
3.0
e6/l
3.0
2.7
0.44
623
3992
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
494
2917
1.77
28.72
1.6
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
709
4618
1.62
28.52
1.5
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4058
36795
1.49
28.38
4.5
4.2
mmol/l
1.3
1.3
5.40
3605
32248
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4287
39329
1.54
28.20
5.9
5.1
mmol/l
6.0
6.1
6.29
3860
34655
(3008757) Leukocyte morphology finding [Identifier] in Blood
137
490
2.84
27.93
3.3
4.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
379
2084
1.88
27.80
2.2
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
137
492
2.83
27.72
1.5
2.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1408
10679
1.44
27.47
1.8
1.7
pmol/l
28374159.6
27335265.4
0.02
1156
8491
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1578
12253
1.42
26.89
3.0
3.1
u/l
32.4
37.5
1.84
1494
11482
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4202
38504
1.50
26.60
5.1
4.8
mmol/l
4.6
4.5
1.61
3800
34455
(3024263) Appearance of Synovial fluid
87
244
3.61
26.54
1.9
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
369
2055
1.86
25.98
1.3
1.3
—
—
—
0
0
(3013512) EKG study
1762
14022
1.39
25.74
5.2
4.4
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
63
146
4.36
25.00
1.6
1.3
%
54.5
58.9
0.38
58
125
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
346
1911
1.87
24.99
2.0
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4152
38101
1.46
24.69
5.0
4.7
mmol/l
1.5
1.5
10.50
3731
33800
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
128
472
2.76
24.68
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4292
39665
1.49
24.40
5.7
5.4
mmol/l
2.6
2.6
1.62
3877
35344
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
106
355
3.03
24.35
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
670
4467
1.57
24.18
1.3
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1018
7420
1.46
24.05
2.7
2.9
mmol/l
0.8
0.8
0.41
928
6816
(3045414) Leukocytes [Presence] in Urine
339
1891
1.85
23.72
2.0
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2032
16702
1.36
23.71
2.4
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
610
3997
1.60
23.68
4.8
3.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
302
1634
1.90
23.24
1.3
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
192
882
2.22
23.07
1.2
1.1
titre
80.0
93.7
0.40
18
59
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1380
10731
1.39
22.50
2.7
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
687
4688
1.54
22.24
2.6
2.4
ug/l
6.0
6.6
0.43
559
3921
(3020779) Urea [Moles/volume] in Serum or Plasma
623
4168
1.56
22.03
5.8
6.2
mmol/l
11.2
11.2
0.09
588
3914
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
53
119
4.49
21.92
1.4
1.3
%
38.0
31.7
0.59
36
81
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
430
2629
1.69
21.91
2.6
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
242
1241
2.00
21.80
1.4
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3518
31626
1.35
21.58
31.7
20.7
%
14.2
13.9
31.92
3468
30806
(3034770) Mitochondria Ab [Titer] in Serum
188
900
2.13
20.40
1.2
1.1
titre
575.0
912.3
—
6
26
(3044640) Blood type and Crossmatch panel - Blood
1727
14085
1.34
20.33
2.8
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
291
1625
1.84
20.28
2.8
2.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1225
9486
1.38
20.10
5.0
4.1
ng/l
174.9
411.9
1.70
1066
8190
(3048929) Epstein Barr virus Ab [Presence] in Serum
147
640
2.33
20.09
1.2
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
718
5063
1.49
19.72
6.6
6.4
%
95.4
95.3
0.15
695
4853
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
201
1010
2.03
19.18
1.4
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
153
697
2.23
18.82
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1202
9376
1.37
18.63
6.4
4.7
kg/l
1.0
1.0
2.07
212
1502
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
612
4230
1.51
18.47
1.9
2.0
g/l
0.2
0.2
1.06
562
3895
(3005322) IgE [Units/volume] in Serum or Plasma
310
1816
1.75
18.40
1.4
1.2
u/ml
284.2
214.6
0.61
284
1651
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
235
1269
1.89
18.21
1.9
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
148
675
2.23
18.16
2.9
4.5
iu/ml
1878.8
3060.2
0.16
16
89
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
776
5655
1.44
17.84
6.5
6.2
kpa
5.0
5.1
0.52
742
5358
(3027801) Oxygen [Partial pressure] in Arterial blood
775
5654
1.44
17.69
6.5
6.2
kpa
11.8
12.0
0.39
743
5352
(3003396) Base excess in Arterial blood by calculation
776
5664
1.44
17.67
6.5
6.1
mmol/l
1.6
1.2
2.02
647
4379
(3012516) Albumin [Mass/volume] in Urine
1671
13786
1.31
17.50
3.3
3.1
mg/l
735.1
317.4
2.07
1080
8500
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
141
646
2.22
17.14
3.0
2.1
mg/l
29.6
26.1
0.23
33
150
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
153
728
2.14
16.92
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
38
81
4.72
16.79
1.1
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
671
4810
1.45
16.78
3.3
3.1
ng/l
226.7
235.2
0.22
611
4398
(3018677) aPTT in Platelet poor plasma by Coagulation assay
952
7286
1.38
16.34
1.9
1.9
s
29.7
30.0
0.70
927
7034
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
115
494
2.36
16.28
1.2
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
20
23
8.73
15.89
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1675
13978
1.29
15.69
3.2
3.1
mmol/l
6.8
6.9
0.14
1382
11393
(3014111) Lactate [Moles/volume] in Serum or Plasma
590
4183
1.46
15.57
6.3
5.8
mmol/l
1.5
1.4
1.05
563
4020
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
123
563
2.21
15.03
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1733
14619
1.28
14.67
4.0
3.9
mg/mmol
8.8
9.3
0.18
1104
8946
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
116
524
2.24
14.65
1.6
2.3
u/ml
31509.6
1102.3
—
8
41
(3002173) Hemoglobin [Mass/volume] in Arterial blood
636
4638
1.42
14.37
7.1
6.8
g/l
116.5
119.6
3.83
619
4468
(3019060) Gas panel - Arterial blood
484
3351
1.49
14.36
4.2
4.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
632
4606
1.42
14.33
3.7
3.4
mmol/l
2.4
2.0
2.11
540
3745
(3011412) CD3 cells [#/volume] in Blood
77
293
2.65
14.13
2.1
2.0
e9/l
1.1
1.0
0.02
39
186
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
124
586
2.14
14.02
1.3
1.3
—
—
—
0
0
(3012544) pH of Venous blood
650
4782
1.41
13.96
3.7
3.4
ph
7.4
7.4
—
9
24
(3030981) Hyaline casts [#/volume] in Urine by Automated count
379
2506
1.55
13.96
3.1
2.7
e6/l
0.2
0.3
1.55
368
2458
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
171
910
1.91
13.92
1.7
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
124
589
2.13
13.84
1.3
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
184
1010
1.85
13.62
1.6
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
132
650
2.06
13.42
1.9
2.1
pg
32.0
32.7
0.94
132
643
(3036670) Protein [Mass/volume] in Synovial fluid
51
159
3.23
13.37
1.4
1.2
g/l
39.1
40.4
0.28
30
75
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
122
584
2.12
13.36
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
145
741
1.98
13.30
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
102
456
2.26
13.24
1.2
1.2
u/ml
281.7
299.3
0.23
57
274
(3025468) Yersinia sp identified in Specimen by Organism specific culture
122
587
2.10
13.19
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
439
3034
1.49
13.13
4.2
3.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
56
188
3.00
12.98
2.1
1.9
e6/l
489.8
488.0
0.01
43
157
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
152
798
1.93
12.91
2.6
3.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
190
1072
1.80
12.88
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1590
13445
1.26
12.77
5.5
5.5
ug/l
2.5
4.3
3.79
1391
11875
(3010503) CD19 cells [#/volume] in Blood
57
196
2.93
12.68
2.2
2.1
e9/l
0.1
0.4
0.77
51
187
(3024522) Salmonella sp identified in Specimen by Organism specific culture
121
590
2.08
12.65
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
122
597
2.07
12.63
1.3
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
623
4629
1.39
12.57
3.7
3.4
kpa
5.9
5.8
0.40
605
4486
(3014576) Chloride [Moles/volume] in Serum or Plasma
784
6068
1.34
12.21
6.5
6.0
mmol/l
104.0
104.2
0.60
761
5910
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
133
681
1.98
12.17
1.2
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
46
144
3.21
12.01
1.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
121
605
2.02
11.85
1.3
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
536
3920
1.41
11.84
7.3
7.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
66
255
2.61
11.81
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
66
255
2.61
11.81
1.3
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
388
2676
1.49
11.71
1.2
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
52
178
2.94
11.69
2.0
2.0
e9/l
0.2
0.2
0.25
45
155
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
86
378
2.30
11.67
1.4
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
427
3004
1.46
11.66
8.0
7.6
%
93.8
93.7
0.10
422
2991
(3042111) Morphology [Interpretation] in Bone marrow Narrative
154
846
1.85
11.43
1.3
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
84
371
2.29
11.28
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
178
1027
1.76
11.23
1.6
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
16
22
7.29
10.98
1.1
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
725
5633
1.33
10.93
4.9
4.9
%
34.4
33.8
0.70
500
3523
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
85
383
2.24
10.90
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
127
666
1.93
10.88
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
162
919
1.79
10.84
1.2
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
523
3869
1.39
10.78
1.3
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
179
1048
1.73
10.75
2.1
2.2
g/l
3.7
3.6
0.16
168
989
(3033658) Prothrombin time (PT) actual/Normal
1291
10839
1.25
10.65
4.4
3.8
%
86.9
85.5
1.13
1265
10562
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
91
426
2.16
10.64
1.5
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
114
586
1.97
10.38
1.4
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
207
1276
1.65
10.27
3.2
3.1
mmol/l
25.1
25.2
0.11
186
1104
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
183
1097
1.69
10.11
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
183
1097
1.69
10.11
1.4
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
99
489
2.04
10.08
1.2
1.3
u/ml
110.0
120.5
0.57
29
109
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
51
188
2.73
10.06
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
51
189
2.72
9.96
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
438
3186
1.41
9.96
6.6
6.2
mmol/l
25.1
24.6
2.20
415
2974
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
85
398
2.15
9.96
1.5
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
125
676
1.87
9.80
2.8
2.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
512
3834
1.37
9.79
3.3
2.9
kpa
4.5
4.4
0.07
492
3703
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
88
422
2.10
9.71
1.1
1.2
u/l
64.4
61.3
0.07
58
287
(3032057) Clostridioides difficile [Presence] in Stool
37
116
3.21
9.70
1.6
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3652
34262
1.23
9.70
28.8
18.6
%
37.7
38.1
1.50
2185
20813
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
30
82
3.67
9.68
2.6
2.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
128
702
1.84
9.61
1.3
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
65
276
2.37
9.61
1.3
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
267
1782
1.53
9.47
2.4
2.7
u/ml
0.4
0.3
0.40
158
1023
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
132
736
1.81
9.41
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
284
1928
1.50
9.30
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
3194
29634
1.20
9.22
4.8
4.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
77
360
2.16
9.09
1.3
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
32
96
3.35
9.01
2.5
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
517
3930
1.35
8.97
2.6
2.3
u/l
35.3
38.5
0.65
445
3314
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
605
4707
1.32
8.96
2.4
2.6
umol/l
7.0
9.7
2.91
517
4055
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
37
122
3.05
8.95
1.3
2.3
u/ml
1162.6
25157.1
—
5
20
(21494815) CD4 cells/100 lymphocytes in Specimen
59
248
2.39
8.95
1.7
2.0
%
43.2
43.6
0.03
13
23
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
130
737
1.78
8.79
1.2
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
352
2521
1.43
8.75
8.2
7.8
mmol/l
24.7
24.4
1.17
320
2336
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
69
314
2.21
8.72
1.5
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
54
221
2.46
8.69
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
24
61
3.95
8.59
1.3
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
41
147
2.80
8.57
1.1
1.1
ng/l
35.2
401.8
—
5
42
(3019768) Coxiella burnetii Ab [Presence] in Serum
12
16
7.52
8.41
1.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
78
379
2.07
8.37
1.6
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
78
379
2.07
8.37
1.6
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
78
379
2.07
8.37
1.6
1.4
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
20
45
4.46
8.35
1.1
1.2
nmol/l
6.7
5.0
0.29
14
33
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
67
3.74
8.33
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
54
226
2.40
8.29
1.6
1.9
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
110
604
1.84
8.29
7.3
6.1
mg/l
12.7
12.5
0.12
98
549
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
312
2212
1.44
8.21
2.8
3.1
pmol/l
4.2
4.4
3.23
263
1900
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
136
798
1.72
8.19
1.6
1.5
—
—
—
0
0
(4268621)
60
267
2.26
8.03
2.3
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
474
3617
1.34
8.01
5.8
4.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
181
1156
1.59
7.86
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
179
1142
1.59
7.81
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
87
452
1.94
7.78
1.1
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
52
221
2.37
7.75
1.1
1.1
nmol/l
3.5
13.8
—
9
52
(42529406) Shigella sp [Presence] in Stool by Culture
181
1161
1.58
7.72
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
49
203
2.43
7.72
2.2
2.1
e6/l
790.6
582.1
0.69
28
78
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
455
3472
1.34
7.69
3.0
2.7
ml/min/173m2
60.8
59.4
0.40
217
1505
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
131
780
1.70
7.52
1.2
1.2
mmol/l
3.9
3.9
0.02
116
728
(3027273) Bicarbonate [Moles/volume] in Venous blood
349
2564
1.39
7.51
3.8
3.2
mmol/l
25.8
25.2
2.50
339
2498
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
26
77
3.39
7.51
1.2
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
15
29
5.18
7.44
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
72
358
2.03
7.32
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
147
909
1.64
7.31
1.2
1.4
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
55
246
2.25
7.31
1.1
1.2
u/l
71.8
85.1
0.68
43
214
(3027456) Digoxin [Moles/volume] in Serum or Plasma
209
1405
1.51
7.24
3.9
3.2
nmol/l
0.8
0.8
0.16
161
1069
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
145
896
1.64
7.24
1.2
1.3
mg/l
1035.2
554.7
0.83
131
844
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
277
1971
1.43
7.18
1.2
1.2
iu/ml
91.6
120.4
0.66
92
675
(3026389) Candida sp identified in Specimen by Organism specific culture
100
561
1.80
7.09
1.4
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
76
390
1.96
7.08
1.3
1.2
u/ml
2.8
5.5
1.75
36
164
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
45
187
2.42
7.07
1.0
1.0
mg/l
249.0
298.3
1.42
37
166
(3028626) Oxygen [Partial pressure] in Capillary blood
171
1106
1.56
7.07
3.2
2.8
kpa
7.7
7.8
0.30
160
1018
(1175426) CD3 cells/100 lymphocytes in Blood
53
237
2.25
7.06
1.6
1.9
%
72.5
71.5
0.16
47
221
(44806118)
84
447
1.89
7.04
1.5
1.4
—
—
—
0
0
(44790047)
84
447
1.89
7.04
1.5
1.4
—
—
—
0
0
(44790048)
84
447
1.89
7.04
1.5
1.4
—
—
—
0
0
(44790049)
84
447
1.89
7.04
1.5
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
228
1570
1.47
7.03
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
133
812
1.65
6.98
1.3
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
36
135
2.68
6.97
1.0
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
51
226
2.27
6.95
1.8
1.9
u/field
1.3
2.2
0.61
31
147
(3014051) Protein [Presence] in Urine by Test strip
159
1017
1.58
6.91
2.7
2.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
52
235
2.23
6.77
1.1
1.2
u/l
22.8
20.8
0.17
40
201
(3047189) Immunofixation for 24 hour Urine
52
235
2.23
6.77
1.4
1.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
11
17
6.48
6.77
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
191
1280
1.51
6.74
1.5
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
46
198
2.34
6.71
1.1
1.1
mg/l
38.2
43.0
0.44
39
170
(3045142) Bone marrow Pathology biopsy report
90
499
1.82
6.65
1.1
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
42
175
2.41
6.59
1.1
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
300
2200
1.39
6.56
3.4
3.5
mmol/l
24.6
24.2
1.33
271
1948
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
110
650
1.71
6.55
1.5
1.4
—
—
—
0
0
(3010421) pH of Blood
190
1285
1.50
6.43
4.7
4.3
ph
7.4
7.4
1.89
162
1082
(3004451) EKG impression Narrative
55
260
2.13
6.43
1.6
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
35
136
2.58
6.35
1.5
1.5
ug/l
0.4
0.4
0.18
21
75
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
159
1039
1.55
6.33
1.4
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
249
1780
1.42
6.32
3.6
3.5
mmol/l
1.4
1.4
0.10
244
1750
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
343
2586
1.35
6.31
9.3
8.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
76
409
1.87
6.20
1.3
1.2
u/ml
1.6
4.2
1.48
30
121
(3004119) Hemoglobin [Mass/volume] in Venous blood
397
3072
1.32
6.12
3.8
3.1
g/l
123.0
126.8
3.38
390
2995
(3021901) Oxygen saturation in Capillary blood
146
945
1.56
6.07
3.0
2.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
96
559
1.73
6.05
2.2
2.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
52
247
2.12
6.03
3.8
4.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
166
1110
1.51
5.96
4.5
4.4
mmol/l
2.9
2.8
0.22
122
769
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
19
54
3.53
5.87
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
49
231
2.13
5.80
1.6
1.9
%
20.3
15.3
0.48
19
88
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
142
928
1.55
5.69
2.2
2.2
%
206.8
205.7
0.04
135
880
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
605
4983
1.24
5.65
5.0
3.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
56
281
2.00
5.64
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
82
467
1.77
5.61
2.4
2.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
54
268
2.03
5.61
2.6
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
84
482
1.76
5.60
3.0
3.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1223
10780
1.18
5.58
4.7
4.8
%
19.8
22.1
7.07
628
5757
(3037692) Legionella sp identified in Specimen by Organism specific culture
34
140
2.44
5.52
1.1
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
200
1412
1.43
5.49
3.7
3.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
165
1123
1.48
5.47
2.4
2.2
g/l
125.3
125.7
0.08
118
820
(1616796) Gas panel - Central venous blood
164
1116
1.48
5.45
3.5
3.8
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
18
52
3.47
5.44
1.4
1.3
mmol/l
6.3
5.7
—
6
28
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
112
2.60
5.37
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
31
124
2.51
5.36
1.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
158
1074
1.49
5.29
3.0
2.5
%
15.6
15.7
0.08
86
548
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
95
574
1.67
5.28
1.2
1.3
nmol/l
0.1
0.3
—
6
48
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
96
586
1.65
5.15
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
43
203
2.13
5.12
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
266
2002
1.35
5.01
4.8
4.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
36
3.90
4.98
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
35
154
2.28
4.94
1.1
1.1
u/l
1.0
1.2
1.34
16
86
(3017569) Oxygen content in Arterial blood
48
240
2.01
4.93
1.6
2.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
37
167
2.22
4.93
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
37
167
2.22
4.93
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
51
261
1.96
4.91
1.5
1.6
u/l
5.0
6.5
0.37
26
119
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
310
2394
1.31
4.90
4.7
3.9
%
46.8
47.1
0.09
304
2368
(3003181) Sodium [Moles/volume] in Urine
142
961
1.49
4.89
1.4
1.3
mmol/l
60.4
61.0
0.07
117
761
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
880
7623
1.19
4.88
3.3
3.3
ug/l
0.7
0.8
2.56
626
5500
(3049717) Cytology report of Urine Cyto stain
260
1961
1.34
4.84
2.7
2.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
127
843
1.52
4.80
1.1
1.1
u/ml
9.0
10.4
—
6
52
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
87
528
1.66
4.80
1.2
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
17
52
3.28
4.74
2.1
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
39
183
2.14
4.74
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
80
477
1.69
4.72
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
188
1354
1.40
4.67
1.8
1.8
s
22.8
21.6
0.99
178
1218
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
49
252
1.95
4.67
1.1
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
44
218
2.03
4.65
1.7
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
44
218
2.03
4.65
1.7
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
44
218
2.03
4.65
1.7
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
44
218
2.03
4.65
1.7
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
333
2618
1.29
4.62
4.5
3.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
39
185
2.12
4.62
1.4
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
117
773
1.53
4.54
1.3
1.4
e6/l
3408.6
1098.7
0.49
88
627
(3000012) Reticulocyte production index
54
290
1.87
4.54
1.7
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
31
135
2.30
4.51
1.5
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
42
209
2.02
4.40
1.1
1.1
u/l
54.9
28.1
0.50
26
149
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
42
209
2.02
4.40
1.1
1.1
u/l
93.0
81.0
0.22
28
151
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
279
2158
1.31
4.39
5.0
4.6
%
1.6
1.6
0.03
266
2024
(3043409) Potassium [Moles/volume] in Arterial blood
207
1532
1.37
4.39
3.9
3.7
mmol/l
3.9
3.9
0.23
190
1419
(4027681)
31
137
2.27
4.37
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
198
1456
1.37
4.37
1.3
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
116
772
1.51
4.37
1.3
1.3
e6/l
20.3
26.2
0.18
82
592
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
14
40
3.51
4.32
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
71
1162
0.61
4.32
1.3
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
204
1511
1.36
4.31
5.9
5.7
mmol/l
1.3
1.3
0.06
182
1342
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
82
506
1.63
4.28
1.0
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
276
2140
1.31
4.27
5.0
4.7
%
0.9
0.9
0.09
261
2010
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
131
902
1.46
4.19
1.6
1.7
iu/l
90.8
4.6
0.49
36
281
(3002256) Pathology report gross observation
660
5651
1.19
4.17
1.4
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
63
365
1.73
4.16
3.7
3.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
26
109
2.39
4.13
1.0
1.1
u/ml
32.0
6.7
—
6
13
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
364
2936
1.26
4.13
1.4
1.6
%
1.6
1.6
0.64
304
2438
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
63
366
1.73
4.13
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
103
2.43
4.12
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
24
97
2.48
4.12
1.2
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
295
2320
1.29
4.11
2.8
2.4
%
0.7
0.7
0.75
284
2220
(3035637) Corticotropin [Mass/volume] in Plasma
72
435
1.66
4.09
1.3
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
16
52
3.08
4.08
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
27
116
2.33
4.07
1.7
2.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
632
5403
1.19
4.06
2.9
3.9
ug/l
10.3
26.6
2.99
513
4470
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
25
104
2.41
4.05
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
69
2.76
4.01
1.8
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
72
439
1.65
3.97
2.6
2.2
u/field
0.8
2.3
3.07
29
128
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
44
232
1.90
3.95
1.3
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
44
232
1.90
3.95
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
125
864
1.46
3.94
1.6
2.5
umol/l
32.4
34.1
0.23
101
713
(3000570) Elastase.pancreatic [Mass/mass] in Stool
179
1320
1.37
3.92
1.5
1.4
ug/g
254.2
264.6
0.35
104
793
(3019174) dRVVT (LA screen)
10
24
4.17
3.88
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
33
158
2.10
3.87
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
78
490
1.60
3.83
2.2
2.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
42
222
1.90
3.76
1.7
2.3
mmol/l
8.7
9.4
0.59
34
174
(3016135) IgD [Mass/volume] in Serum
6
5
12.01
3.76
1.0
1.0
mg/l
18.0
46.7
—
6
5
(21494814) CD8 cells/100 lymphocytes in Specimen
29
134
2.17
3.72
1.7
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
82
528
1.56
3.65
1.4
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
56
2.86
3.62
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
79
506
1.57
3.60
1.2
1.3
nmol/l
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
62
2.75
3.58
1.2
1.1
—
—
—
0
0
(4133840)
17
62
2.75
3.58
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
130
924
1.42
3.57
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
23
98
2.35
3.57
1.0
1.1
miu/ml
1762.2
1696.0
0.10
23
98
(3024928) Oxygen saturation in Venous blood
134
959
1.41
3.54
2.6
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1084
9767
1.14
3.50
1.4
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
39
207
1.89
3.47
1.2
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
38
200
1.91
3.47
2.0
2.5
ml
1894.2
1780.3
0.27
33
169
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
15
52
2.89
3.46
2.0
2.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
41
222
1.85
3.44
1.1
1.3
u/ml
0.1
1.5
1.83
19
122
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
54
320
1.69
3.36
1.3
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
15
53
2.84
3.35
2.0
2.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
44
246
1.80
3.35
2.1
3.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
43
239
1.81
3.34
1.0
1.0
mg/l
315.4
288.2
1.38
37
204
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
139
1013
1.38
3.33
2.4
2.6
mg/l
1.9
1.7
1.26
115
891
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
36
189
1.91
3.33
1.2
1.2
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
21
89
2.37
3.31
1.9
2.1
ug/l
5.8
3.3
—
10
33
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
89
2.37
3.31
1.0
1.1
%
107.9
81.3
—
10
46
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
66
415
1.60
3.28
1.5
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
149
2.02
3.24
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1176
10700
1.13
3.24
1.6
1.6
mmol/l
1.4
1.3
2.61
973
8769
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
20
84
2.39
3.22
1.2
1.3
%
115.3
114.7
0.04
15
72
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
38
3.16
3.21
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
19
78
2.44
3.21
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
30
150
2.01
3.19
1.1
1.1
ratio
1.1
1.1
0.01
11
42
(4146454)
82
547
1.51
3.16
2.4
2.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
66
421
1.58
3.11
1.1
1.2
—
—
—
0
0
(4024509)
79
526
1.51
3.08
1.7
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
68
438
1.56
3.08
1.0
1.1
g/l
1.6
1.6
0.55
62
385
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
226
1790
1.27
3.06
2.4
3.1
u/ml
95.2
3745.4
1.55
181
1512
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
8
16
5.01
3.05
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
50
299
1.68
3.04
1.9
2.4
ph
7.4
7.4
0.00
20
98
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
18
74
2.44
3.04
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
53
324
1.64
2.98
1.5
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
69
452
1.53
2.92
1.4
1.3
u/l
13.0
13.4
0.06
59
358
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
19
82
2.32
2.90
1.4
1.5
ng/l
95.5
134.9
1.07
19
82
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
50
304
1.65
2.88
1.3
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
6
9
6.67
2.86
1.0
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
77
522
1.48
2.79
1.3
1.3
mu/l
52.1
55.5
0.10
67
458
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
23
110
2.10
2.78
1.1
1.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
5
6
8.34
2.75
1.6
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
30
159
1.89
2.75
2.9
2.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
26
131
1.99
2.74
1.4
1.8
%
170.2
172.0
0.03
26
120
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
52
324
1.61
2.74
1.1
1.1
u/ml
3.5
2.2
—
7
95
(4211845)
41
240
1.71
2.73
4.9
3.9
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
20
91
2.20
2.73
1.1
1.3
%
113.7
81.3
—
10
49
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
108
785
1.38
2.70
1.2
1.2
u/l
31.3
45.2
1.11
98
683
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
11
37
2.98
2.69
1.4
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
30
161
1.87
2.65
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
139
1055
1.33
2.64
1.2
1.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
22
106
2.08
2.62
1.3
1.3
nmol/l
162.9
126.9
0.41
13
70
(4010399)
354
3001
1.19
2.57
1.5
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
114
2.02
2.55
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
307
1.60
2.55
1.3
1.4
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
6
11
5.46
2.54
1.7
1.3
nmol/l
616.7
356.0
—
6
11
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
71
484
1.47
2.53
1.3
1.3
pmol/l
303.9
272.2
0.32
49
373
(3002619) Bacteria identified in Specimen by Culture
18
81
2.23
2.53
1.3
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
678
6058
1.14
2.48
10.4
8.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
102
2.06
2.46
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
31
173
1.80
2.45
1.8
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
24
123
1.96
2.44
1.2
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
52
335
1.56
2.42
1.2
1.1
mmol/l
31.6
34.2
0.44
43
270
(3051611) Lipemic interference index of Serum or Plasma
75
523
1.44
2.40
3.7
3.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
12
5.00
2.40
1.2
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
24
124
1.94
2.39
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
366
3135
1.18
2.38
1.5
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
12
46
2.61
2.35
5.6
4.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
16
71
2.26
2.34
1.5
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
40
244
1.64
2.33
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
36
214
1.69
2.31
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
45
284
1.59
2.30
1.5
1.5
ml
1912.0
1728.0
—
8
80
(3051593) INR in Capillary blood by Coagulation assay
46
293
1.58
2.27
7.6
15.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
30
171
1.76
2.24
1.9
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
30
171
1.76
2.24
1.9
1.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
49
318
1.55
2.23
1.2
1.5
—
1451.4
—
0
7
(3041672) Baker's yeast Ab [Presence] in Serum
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
68
474
1.44
2.21
1.4
1.3
mosm/kgh2o
272.8
275.1
0.39
52
339
(3006270) Folate [Moles/volume] in Blood
67
467
1.44
2.18
1.2
1.2
nmol/l
330.0
328.4
0.02
54
363
(3044009) aPTT.lupus sensitive (LA screen)
8
24
3.34
2.18
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
30
3.00
2.14
1.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
81
587
1.39
2.13
1.5
1.8
ug/l
20.8
23.8
0.42
75
576
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
18
88
2.05
2.11
2.6
2.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
84
615
1.37
2.08
1.4
1.4
e6/l
33119.6
66458.0
0.68
39
369
(3044242) Glucose [Moles/volume] in Arterial blood
42
268
1.57
2.08
1.5
1.9
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
10
5.00
2.07
1.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
82
2.08
2.06
1.1
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
91
677
1.35
2.05
1.4
1.5
e6/l
1329.6
1919.3
1.25
57
492
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
22
118
1.87
2.01
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
36
224
1.61
1.99
5.2
4.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
57
2.28
1.97
1.7
1.7
e6/l
96.3
146.8
—
8
22
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
41
264
1.56
1.97
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
42
272
1.55
1.97
1.3
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
171
1.70
1.96
1.3
1.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
17
84
2.03
1.95
1.1
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
42
273
1.54
1.94
1.3
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
27
2.97
1.93
1.3
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
45
2.45
1.92
2.2
3.1
u/field
0.5
0.5
0.13
11
45
(3018572) Chloride [Moles/volume] in Blood
139
1107
1.26
1.92
6.7
6.3
mmol/l
104.8
104.9
0.13
127
988
(3039000) Anion gap in Blood
139
1107
1.26
1.92
6.7
6.2
mmol/l
11.3
11.2
0.16
127
988
(3013139) Helicobacter pylori Ag [Presence] in Stool
311
2682
1.17
1.92
1.2
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
10
39
2.57
1.92
1.2
1.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
40
258
1.55
1.91
2.8
2.2
umol/l
16.3
25.8
—
6
22
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
57
397
1.44
1.90
1.1
1.1
—
—
—
0
0
(4035726)
446
3953
1.14
1.89
1.3
1.4
—
—
—
0
0
(4015189)
25
143
1.75
1.88
3.0
2.2
—
—
—
0
0
(4306422)
56
390
1.44
1.87
1.2
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
142
0.35
1.87
1.2
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
28
166
1.69
1.87
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
79
585
1.36
1.86
12.0
6.2
mmol/l
7.8
7.5
0.20
70
482
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
101
778
1.30
1.83
1.4
1.5
g/l
31.2
31.0
0.05
91
694
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
101
1.88
1.80
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
35
2.57
1.80
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
47
2.34
1.77
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
78
582
1.35
1.77
1.5
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
159
1303
1.23
1.74
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
18
96
1.88
1.70
1.0
1.5
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
14
68
2.06
1.70
2.0
2.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
79
595
1.33
1.69
1.4
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
50
349
1.44
1.68
1.9
1.9
ug/l
2.8
3.3
0.25
39
307
(3035320) C reactive protein [Mass/volume] in Body fluid
46
316
1.46
1.68
2.5
2.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
172
1.63
1.66
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
49
342
1.44
1.65
2.0
2.0
ug/l
2.1
2.1
0.01
34
295
(3051387) C reactive protein [Mass/volume] in Capillary blood
131
1062
1.24
1.60
5.8
3.7
mg/l
36.9
29.2
1.31
98
691
(3022689) Creatine [Moles/volume] in Urine
20
113
1.77
1.60
1.4
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
31
198
1.57
1.59
1.5
2.7
%
46.7
37.6
0.79
12
75
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
141
1154
1.23
1.59
2.1
2.3
ug/min
130.1
83.8
0.34
80
651
(3050794) Legionella sp Ab [Presence] in Serum
8
33
2.43
1.53
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
133
1618
0.82
1.52
1.9
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
20
115
1.74
1.52
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
80
1031
0.77
1.51
1.5
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
19
108
1.76
1.50
1.4
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
242
2098
1.16
1.46
1.9
2.1
nmol/l
11.4
11.8
0.32
199
1792
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
5
16
3.13
1.44
1.4
1.1
mmol/l
6.1
5.4
—
5
8
(3016750) Collection duration of Urine
38
263
1.45
1.38
1.6
1.9
min
486.6
490.4
0.07
25
179
(3016330) Potassium [Moles/time] in 24 hour Urine
9
41
2.20
1.36
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
15
82
1.83
1.35
1.1
1.5
ug/l
8.6
10.0
0.93
15
82
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
17
97
1.76
1.34
1.5
2.0
%
192.9
201.4
0.12
17
88
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
124
1023
1.22
1.34
2.5
3.0
u/ml
118.8
799.5
1.69
110
933
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
42
2.14
1.33
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
18
105
1.72
1.33
3.2
2.5
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
11
54
2.04
1.32
1.3
1.2
%
35.8
47.3
—
5
21
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
66
506
1.31
1.31
1.2
1.3
u/l
818.6
304.3
1.03
61
477
(3005011) Chlamydia sp Ab [Titer] in Serum
9
43
2.09
1.30
1.3
1.8
—
—
—
0
0
(44806071)
8
34
2.35
1.29
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
137
1.61
1.29
1.3
1.4
umol/l
73.7
118.2
0.75
15
77
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
18
2.78
1.28
2.0
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
169
1.54
1.28
1.9
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
169
1.54
1.28
1.9
2.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
44
2.05
1.26
1.8
1.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29
194
1.50
1.26
1.2
1.9
nmol/l
15.6
14.9
0.17
29
177
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
123
1.63
1.23
1.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
28
187
1.50
1.23
1.3
1.5
g/l
1.0
0.9
0.16
28
187
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
27
179
1.51
1.23
1.1
1.1
iu/ml
14.6
11.4
—
6
43
(3034274) Bile acid [Moles/volume] in Serum --fasting
26
171
1.52
1.23
1.1
1.3
umol/l
19.9
12.7
0.22
19
110
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
16
93
1.72
1.21
1.1
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
31
213
1.46
1.20
1.1
1.2
nmol/l
1.2
1.1
0.05
20
160
(3025018) Bordetella pertussis Ab [Titer] in Serum
24
156
1.54
1.19
1.5
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
64
498
1.29
1.17
1.1
1.1
iu/ml
2.0
68.2
2.01
16
91
(3003338) MCHC [Mass/volume]
3216
31504
1.06
1.12
36.3
22.6
g/l
327.9
330.8
61.11
3188
31150
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
51
388
1.32
1.11
1.1
1.3
u/l
15.1
12.5
0.58
46
353
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
10
51
1.96
1.11
1.0
1.2
—
75.9
—
0
15
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
10
51
1.96
1.11
1.0
1.2
—
78.3
—
0
16
(3038177) Helicobacter pylori Ab [Presence] in Serum
59
460
1.29
1.08
1.3
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
27
186
1.45
1.05
1.1
4.5
mg/l
74.4
66.1
0.24
18
125
(1617658) Protocol used for examination of sentinel lymph nodes
25
359
0.69
1.03
1.2
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
91
752
1.21
1.03
2.3
2.1
%
58.9
61.5
0.50
91
747
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
221
1.41
1.02
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
53
413
1.29
1.00
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
131
1.53
0.99
1.3
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
76
1.71
0.98
5.9
8.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
70
566
1.24
0.98
1.5
1.7
nmol/l
36.6
45.7
3.65
65
539
(3008037) Lactate [Moles/volume] in Venous blood
147
1275
1.16
0.97
4.3
3.3
mmol/l
1.7
1.6
0.33
142
1250
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
65
522
1.25
0.97
1.4
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
67
823
0.81
0.94
1.8
1.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
37
1.89
0.94
1.0
1.1
—
—
—
0
0
(4198724)
7
37
1.89
0.94
1.1
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
16
101
1.59
0.93
1.2
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
31
226
1.37
0.92
2.5
2.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
28
2.14
0.91
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
78
1.67
0.91
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
15
94
1.60
0.90
5.7
8.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
29
2.07
0.89
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
135
1.48
0.89
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
55
439
1.26
0.88
1.2
1.2
miu/ml
128.8
211.0
1.33
19
152
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
56
1.79
0.87
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
39
302
1.29
0.81
1.5
2.5
mmol/l
7.2
7.1
0.08
20
202
(3035933) Granulocytes/100 leukocytes in Blood
10
58
1.73
0.79
1.4
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
58
1.73
0.79
1.4
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
33
1.82
0.79
2.0
4.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
305
0.72
0.79
1.0
1.1
u/ml
0.3
1.4
—
6
113
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
48
1.67
0.78
1.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
24
326
0.73
0.76
1.0
1.0
ng/l
51.5
44.7
0.33
17
208
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
24
326
0.73
0.76
1.0
1.0
ng/l
628.4
696.5
0.33
17
201
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
34
1.77
0.76
1.2
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
324
0.74
0.74
1.0
1.0
ng/l
374.2
324.7
0.40
18
209
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
38
1.84
0.73
1.0
1.2
u/l
7.0
12.2
—
7
38
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
38
1.84
0.73
1.3
1.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
62
515
1.21
0.73
1.2
1.4
mmol/l
6.4
6.4
0.03
56
479
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
59
488
1.21
0.72
1.1
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
103
895
1.15
0.72
1.3
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
67
796
0.84
0.72
3.6
3.7
u/ml
34.0
43.3
0.53
67
771
(3028717) Thiamine [Mass/volume] in Blood
7
40
1.75
0.71
1.1
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
63
528
1.20
0.68
1.4
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
42
1.67
0.68
1.9
1.4
—
—
—
0
0
(4281824)
41
507
0.81
0.67
1.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
43
1.63
0.66
2.0
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
18
249
0.72
0.66
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
86
1.51
0.66
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
44
1.59
0.65
1.4
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
11
70
1.57
0.65
1.5
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
62
1.61
0.65
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
36
286
1.26
0.65
4.2
4.8
u/ml
19.7
67.3
—
6
80
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
29
1.72
0.64
1.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
50
1.60
0.61
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
86
750
1.15
0.60
2.8
2.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
229
2112
1.09
0.60
3.6
4.1
u/ml
54.0
86.8
1.24
221
2025
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
51
1.57
0.60
21.8
11.7
mmol/l
3.9
5.3
—
8
51
(40758358) Immune stain study
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
255
0.74
0.59
1.0
1.1
u/ml
0.5
1.4
—
7
104
(40768795) Lymph node Pathology biopsy report
33
411
0.80
0.59
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
52
1.54
0.59
1.4
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
89
1.46
0.58
1.2
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
46
383
1.20
0.56
2.0
2.1
ml
769.5
624.3
1.19
30
227
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
40
329
1.22
0.55
1.3
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
78
890
0.87
0.55
1.6
1.7
mg/l
4.4
3.5
0.40
63
670
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
18
133
1.35
0.55
1.0
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
262
0.76
0.54
1.0
1.1
u/ml
1.8
2.8
—
9
115
(3000034) Microalbumin [Mass/volume] in Urine
52
440
1.18
0.54
2.9
3.0
mg/l
81.9
33.8
0.42
38
334
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
82
1.46
0.54
2.3
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
35
285
1.23
0.54
2.5
3.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
55
469
1.17
0.53
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
39
1.54
0.53
1.5
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
39
1.54
0.53
1.5
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
39
1.54
0.53
1.5
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
9
62
1.45
0.53
5.4
8.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
94
835
1.13
0.53
1.3
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
66
1.52
0.52
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1116
10847
1.04
0.50
3.2
3.4
—
—
—
0
0
(4094501)
117
1058
1.11
0.49
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
84
1.43
0.49
1.3
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
166
0.72
0.47
1.0
1.1
u/ml
0.2
2.0
—
5
65
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
146
1.30
0.47
2.7
2.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
49
1.43
0.46
1.1
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
138
1.31
0.45
1.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
36
304
1.19
0.41
1.1
1.3
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.2
—
94.9
—
0
15
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
11
79
1.39
0.40
1.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
79
1.39
0.40
1.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
179
1.23
0.37
2.0
1.5
u/l
4767.4
859.8
—
10
68
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
8
112
0.71
0.37
1.0
1.0
%
88.4
91.0
—
8
79
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
25
207
1.21
0.36
5.2
6.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
180
1.22
0.35
1.2
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
42
1.43
0.35
1.2
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
44
1.36
0.34
1.5
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
22
181
1.22
0.34
1.2
1.5
%
3.1
2.6
0.08
17
147
(44813793)
24
200
1.20
0.33
1.2
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
46
1.30
0.33
1.2
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
160
1505
1.07
0.32
5.8
4.7
—
—
—
0
0
(1002224) Polysomnography panel
99
915
1.08
0.31
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
16
129
1.24
0.30
1.3
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
27
232
1.16
0.28
1.1
1.2
mmol/l
15.5
11.7
—
7
74
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
103
1.26
0.28
1.1
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
13
103
1.26
0.28
1.2
2.4
mu/l
11.3
21.8
2.05
13
95
(40768441) Liver Pathology biopsy report
21
247
0.85
0.27
1.2
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
43
385
1.12
0.26
1.3
1.2
mmol/l
8.1
7.8
0.24
32
268
(44806420)
15
182
0.82
0.26
2.7
2.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
67
1.19
0.26
1.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
34
301
1.13
0.25
1.4
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
22
189
1.16
0.24
1.1
1.2
nmol/l
146.1
139.3
0.22
22
189
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
152
1.18
0.23
1.2
1.3
ug/l
386.1
345.0
0.03
12
82
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
106
1.23
0.23
1.5
2.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3007542) Rye IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
24
211
1.14
0.20
1.3
1.5
%
63.1
67.2
0.24
17
167
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
50
1.20
0.19
2.0
1.5
umol/l
39.8
43.1
—
6
50
(3011648) Oxygen content in Venous blood
31
344
0.90
0.19
1.9
1.6
%
9.2
10.7
1.18
31
344
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
175
0.86
0.18
1.0
1.1
u/ml
1.1
1.6
—
7
70
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
56
522
1.07
0.18
3.7
3.6
u/ml
24.4
47.2
3.01
56
514
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
60
1.17
0.17
1.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
33
300
1.10
0.17
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
262
1.11
0.17
1.2
1.5
—
—
—
0
0
(4034850)
133
1383
0.96
0.16
13.2
11.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
78
1.15
0.15
1.7
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
22
197
1.12
0.15
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
182
0.88
0.15
1.2
1.5
nmol/l
0.2
0.2
—
9
133
(3011288) Drugs identified in Urine by Screen method
12
139
0.86
0.14
1.5
1.9
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
47
499
0.94
0.13
3.1
4.4
umol/l
344.5
342.2
0.04
36
428
(3051101) Glucose [Moles/volume] in Cord blood
12
104
1.15
0.12
5.2
6.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
12
104
1.15
0.12
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
364
3577
1.02
0.12
1.5
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
271
0.92
0.11
1.2
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
65
0.77
0.08
3.8
4.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
74
716
1.03
0.08
1.3
1.5
nmol/l
0.8
0.8
0.21
62
576
(3024932) HLA-DR beta [Type]
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
9
84
1.07
0.07
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
78
802
0.97
0.07
1.7
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
88
1.02
0.07
1.6
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
24
253
0.95
0.05
2.4
2.1
ug/min
130.1
137.3
—
8
57
(3025130) Human papilloma virus identified in Specimen
26
273
0.95
0.05
1.6
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
458
4548
1.01
0.04
1.4
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
26
272
0.96
0.04
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
61
596
1.02
0.04
1.6
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
121
1.07
0.03
2.2
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
92
1.09
0.03
1.1
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
112
1.07
0.03
1.5
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
259
0.97
0.02
1.2
1.9
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
132
1.06
0.02
1.1
1.4
pmol/l
66.4
62.4
—
5
47
(40768793) Breast Pathology biopsy report
101
1022
0.99
0.02
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
24
232
1.03
0.02
1.3
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
10
107
0.93
0.02
1.1
1.1
umol/24h
0.6
0.7
—
5
48
(3027008) Opiates [Presence] in Urine
24
233
1.03
0.01
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
104
1.06
0.01
1.5
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
216
0.97
0.00
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
24
234
1.03
0.00
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
227
1.01
0.00
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
46
462
1.00
0.00
1.5
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
110
1.00
0.00
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
177
1.02
0.00
1.2
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
49
1.02
0.00
1.2
1.1
umol/24h
1.7
1.7
—
5
49
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
7.0
—
0
8
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
1.3
—
0
9
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
1.4
—
0
7
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1740.0
—
0
5
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
3776.0
—
0
5
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
58
0.86
0.00
1.0
1.2
u/l
21.8
22.1
—
5
39
(3024471) HLA-A [Type]
7
73
0.96
0.00
1.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.1
—
0
6
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
6
69
0.87
0.00
1.0
1.4
%
73.9
76.5
—
6
58
(3023511) Choriogonadotropin [Units/volume] in Urine
7
71
0.99
0.00
1.1
1.3
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
16.4
—
0
5
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
93
0.97
0.00
1.1
1.6
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
5
55
0.91
0.00
1.2
1.2
mg/l
3.5
7.4
—
5
49
Mortality – FinRegistry
↥Association
Association between endpoint M13_POLYMYALGIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_POLYMYALGIA | 1.434 [1.32, 1.56] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.112 |
During the follow-up period (1.1.1998 — 31.12.2019), 9271 out of 20812 females with M13_POLYMYALGIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_POLYMYALGIA | 1.301 [1.17, 1.44] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 4250 out of 10085 males with M13_POLYMYALGIA died.
Mortality risk
Mortality risk for people of age
years, who have M13_POLYMYALGIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.123% | 0.255% |
| 5 | 0.776% | 1.575% |
| 10 | 2.078% | 3.809% |
| 15 | 3.839% | 7.141% |
| 20 | 6.805% | 12.182% |
Relationships between endpoints
↥Index endpoint: M13_POLYMYALGIA – Polymyalgia rheumatica
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data